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Roles of Cytosolic Nucleic Acid Sensors in Cancer and Infection
Abstract
Pattern recognition receptors are innate immune sensors that recognize pathogen-associated molecular
patterns (PAMPs) and danger-associated molecular patterns (DAMPs) with crucial roles in host defense
against microbial infection, autoimmune diseases and cancer. Cytosolic nucleic acids including DNA and
RNA originate from pathogens or self-cells, which form major groups of PAMPs and DAMPs. A range of
nucleic acid sensors have evolved to sense various types of nucleic acids. How different DNA-sensing
pathways regulate microbial infection and cancer is the focus of this dissertation.
Stimulator of IFN genes (STING) is a cytosolic innate immune sensor for cyclic dinucleotides that also
serves a dual role as an adaptor molecule for a number of intracellular DNA receptors. A physiological
role for STING in cancer was previously unknown. We showed that STING-deficient mice were highly
susceptible to colitis-associated colorectal cancer. Colons of STING-deficient mice exhibited significant
intestinal damage and overt proliferation with increased levels of pro-inflammatory cytokines during early
stages of tumorigenesis, uncovering an unexpected and important role for STING in mediating protection
against colorectal tumorigenesis.
Absent in melanoma 2 (AIM2) forms an inflammasome with ASC and caspase-1 upon recognition of
double-stranded DNA (dsDNA) in the cytosol leading to caspase-1 activation and caspase-1-dependent
pyroptosis and release of cytokines IL-1 and IL-18. Mutations in AIM2 are frequently identified in patients
with colorectal cancer, but how AIM2 modulates colonic tumorigenesis is unknown. We found that
AIM2-deficient mice were hypersusceptible to colonic tumor development. While production of
inflammasome-associated cytokines and other inflammatory mediators was largely intact in
AIM2-deficient mice, intestinal stem cells lacking AIM2 were prone to uncontrolled proliferation. Aberrant
Wnt signaling expanded a population of tumor-initiating stem cells in the absence of AIM2 driving the
tumor development in AIM2-deficient mice. In addition to its role in cancer, AIM2 recognizes bacteria
including Francisella tularensis subspecies novicida (F. novicida) and induces inflammasome responses.
Type I interferon (IFN) signaling drives activation of AIM2 inflammasome in F. novicida-infected
macrophages; however, the relative contribution of IFNs and inflammasome responses in host defense
against F. novicida infection is less understood. We found intact AIM2 inflammasome responses in mice
lacking type I IFN signaling during infection with F. novicida. Lack of type I IFN signaling conferred
protection to F. novicida infection in contrast to the increased susceptibility in AIM2-deficient mice.
Interestingly, mice lacking both AIM2 and IFNAR2 were protected against the infection indicating a
dominant role for type I IFNs in mediating detrimental responses despite the protective AIM2
inflammasome responses. Gasdermin D (GSDMD) is activated by caspase-1 to generate pores on the
plasma membrane to induce pyroptosis downstream of the AIM2 inflammasome. We also demonstrated
that mice lacking GSDMD were highly susceptible to F. novicida infection. Interestingly, GSDMD is required
for optimal caspase-1 activation during F. novicida infection, providing protection to the host during the
infection.
In addition, we identified differential mechanisms regulating expression of inflammasome-associated
cytokines IL-1β and IL-18. IL-1β is only induced in response to inflammatory stimuli and its expression is
not sustained during chronic treatment, while IL-18 is constitutively expressed and further induced after
the stimulation in a type I IFN signaling-dependent manner.
Overall, this dissertation addresses protective roles for cytosolic nucleic acid-sensing molecules, STING
and AIM2, in colon cancer, uncovers an interplay between the AIM2 inflammasome and type IFN signaling
during F. novicida infection, and demonstrates a novel function for GSDMD in regulating AIM2
inflammasome. The dissertation finally describes distinctive mechanisms governing inflammasome-

associated cytokines IL-1β and IL-18.
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ABSTRACT
Pattern recognition receptors are innate immune sensors that recognize pathogenassociated molecular patterns (PAMPs) and danger-associated molecular patterns
(DAMPs) with crucial roles in host defense against microbial infection, autoimmune
diseases and cancer. Cytosolic nucleic acids including DNA and RNA originate from
pathogens or self-cells, which form major groups of PAMPs and DAMPs. A range of
nucleic acid sensors have evolved to sense various types of nucleic acids. How different
DNA-sensing pathways regulate microbial infection and cancer is the focus of this
dissertation.
Stimulator of IFN genes (STING) is a cytosolic innate immune sensor for cyclic
dinucleotides that also serves a dual role as an adaptor molecule for a number of
intracellular DNA receptors. A physiological role for STING in cancer was previously
unknown. We showed that STING-deficient mice were highly susceptible to colitisassociated colorectal cancer. Colons of STING-deficient mice exhibited significant
intestinal damage and overt proliferation with increased levels of pro-inflammatory
cytokines during early stages of tumorigenesis, uncovering an unexpected and important
role for STING in mediating protection against colorectal tumorigenesis.
Absent in melanoma 2 (AIM2) forms an inflammasome with ASC and caspase-1
upon recognition of double-stranded DNA (dsDNA) in the cytosol leading to caspase-1
activation and caspase-1-dependent pyroptosis and release of cytokines IL-1 and IL-18.
Mutations in AIM2 are frequently identified in patients with colorectal cancer, but how
AIM2 modulates colonic tumorigenesis is unknown. We found that AIM2-deficient mice
were hypersusceptible to colonic tumor development. While production of
inflammasome-associated cytokines and other inflammatory mediators was largely intact
in AIM2-deficient mice, intestinal stem cells lacking AIM2 were prone to uncontrolled
proliferation. Aberrant Wnt signaling expanded a population of tumor-initiating stem
cells in the absence of AIM2 driving the tumor development in AIM2-deficient mice. In
addition to its role in cancer, AIM2 recognizes bacteria including Francisella tularensis
subspecies novicida (F. novicida) and induces inflammasome responses. Type I
interferon (IFN) signaling drives activation of AIM2 inflammasome in F. novicidainfected macrophages; however, the relative contribution of IFNs and inflammasome
responses in host defense against F. novicida infection is less understood. We found
intact AIM2 inflammasome responses in mice lacking type I IFN signaling during
infection with F. novicida. Lack of type I IFN signaling conferred protection to F.
novicida infection in contrast to the increased susceptibility in AIM2-deficient mice.
Interestingly, mice lacking both AIM2 and IFNAR2 were protected against the infection
indicating a dominant role for type I IFNs in mediating detrimental responses despite the
protective AIM2 inflammasome responses. Gasdermin D (GSDMD) is activated by
caspase-1 to generate pores on the plasma membrane to induce pyroptosis downstream of
the AIM2 inflammasome. We also demonstrated that mice lacking GSDMD were highly
susceptible to F. novicida infection. Interestingly, GSDMD is required for optimal
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caspase-1 activation during F. novicida infection, providing protection to the host during
the infection.
In addition, we identified differential mechanisms regulating expression of
inflammasome-associated cytokines IL-1 and IL-18. IL-1 is only induced in response
to inflammatory stimuli and its expression is not sustained during chronic treatment,
while IL-18 is constitutively expressed and further induced after the stimulation in a type
I IFN signaling-dependent manner.
Overall, this dissertation addresses protective roles for cytosolic nucleic acidsensing molecules, STING and AIM2, in colon cancer, uncovers an interplay between the
AIM2 inflammasome and type IFN signaling during F. novicida infection, and
demonstrates a novel function for GSDMD in regulating AIM2 inflammasome. The
dissertation finally describes distinctive mechanisms governing inflammasome-associated
cytokines IL-1 and IL-18.
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CHAPTER 1.

INTRODUCTION

Background
Cytosolic Nucleic Acids Sensing by Innate Immune Receptors
Pattern recognition receptors are germ-line encoded, innate immune sensors that
recognize conserved molecules derived from microbes or disturbance of homeostatic selfcells, namely PAMPs or DAMPs. Cytosolic nucleic acids such as DNA and RNA form a
major group of PAMPs and DAMPs, which can be utilized by microbes including
viruses, bacteria and fungi as genetic materials and are sensed by cytosolic nucleic acids
sensors upon being released into cytoplasm during the life cycle of the microbes. Under
certain conditions, nucleic acids of self-origin gain access to the cytoplasm and are
recognized by cytosolic sensors leading to autoimmunity [1].
RNA sensors retinoic acid inducible gene I (RIG-I) and melanoma differentiationassociated protein 5 (MDA5) recognize short and long RNA fragments respectively [2].
RIG-I also detects 5’-tri-phosphate and di-phosphate RNA [3-5]. A common adaptor,
mitochondrial antiviral-signaling protein (MAVS) is activated downstream of RIG-I or
MDA5 to induce production of type I IFNs and other inflammatory cytokines [6-9]. RIGI and MDA5 are critical in mediating immune responses to a variety of RNA viruses,
such as influenza virus, hepatitis C virus and myocarditis virus [10, 11]. On the other
hand, cytosolic DNA is sensed mainly by cyclic GMP-AMP synthase (cGAS)- STING
pathway and AIM2, which will be discussed in details below.
Recognition of Cytosolic DNA by cGAS-STING Pathway and Their Potential Role
in Colon Cancer
DNA sensor, cGAS, recognizes dsDNA in the cytoplasm and mediates synthesis
of 2’3’-cyclic GMP-AMP (cGAMP), which binds and activates downstream adaptor
STING (Figure 1-1) [12-16]. Bacteria-derived cyclic-di-AMP (c-di-AMP) and cyclic-diGMP (c-di-GMP) in the cytoplasm can also bind and activate STING, placing STING as
a direct sensor for cytosolic cyclic dinucleotides [17]. Activated STING recruits TANKbinding kinase 1 (TBK1) to induce phosphorylation of interferon-regulatory factor (IRF)
3 and IRF3-mediated expression of type I IFNs and other cytokines [18-20]. The adaptor
STING has been shown to mount host defense against infection by DNA and RNA
viruses and bacteria such as Francisella, Listeria and Mycobacterium genera [21]. The
RNA-sensing pathway has been implicated to play a role in cancer biology in addition to
its critical function in host defense against viral and bacterial infection. Treatment of
DNA demethylation agents to colon tumor cells induces viral mimicry, leading to MDA5
and MAVS-dependent production of IFNs with anti-tumor abilities [23]. However, the
role of the STING-mediated DNA-sensing pathway in cancer, particularly colon cancer,
is rather understudied. Colon cancer is the 3rd most commonly diagnosed cancer and 4th
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Figure 1-1. Diagram of cGAS-STING pathway.
cGAS senses and binds to cytosolic dsDNA leading to production of cGAMP. cGAMP
then binds and activates the downstream adaptor STING to induce recruitment of TBK1
and phosphorylation of IRF3. Phosphorylated IRF3 forms dimers to enter the nucleus to
mediate transcription of type I IFNs and other inflammatory cytokines. Bacteria such as
L. monocytogenes release c-di-AMP and c-di-GMP into the cytosol and activate STING
directly [17, 22].
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leading cause for cancer-related deaths worldwide [24]. The incidence and mortality of
colon cancer are rapidly increasing in developing countries [25]. Inflammation functions
as a driving force to promote colon tumorigenesis. Clinical data support this notion by
observing increased probability for patients with ulcerative colitis to develop colon
cancer [26]. Moreover, previous studies have suggested that innate immune sensors can
modulate the magnitude of colon inflammation thereby regulating development of colon
cancer [27-31], underscoring a potential role for the DNA-sensing pathway governed by
cGAS and STING in colitis-associated cancer.
AIM2 in Colon Cancer and Francisella Infection
dsDNA in the cytoplasm can also be recognized by AIM2 (Figure 1-2) [32-35].
AIM2 binds to DNA via a HIN200 domain which allows its PYRIN domain to interact
with the PYRIN domain of the bipartite adaptor molecule ASC [36]. The CARD domain
of ASC recruits and interacts with the CARD domain of caspase-1 to form a multiprotein complex named the inflammasome [36]. The AIM2 inflammasome mediates
activation of caspase-1 leading to caspase-1-depdendent maturation and secretion of IL1 and IL-18 and induction of pyroptosis. The AIM2 gene was initially isolated by
investigating tumorigenicity of melanoma cells [37]. Later studies identified mutations
and reduced expression of AIM2 gene in human colon tumors and colon tumor cell lines
[38-40]. Moreover, a poorer survival rate has been reported in colon cancer patients
bearing lower AIM2 expression in the tumors [40]. Besides its potential role in colon
cancer, AIM2 has been established as a critical sensor for microbial infection. AIM2 is
responsible for inducing inflammasome responses upon infection by viruses including
mouse cytomegalovirus (MCMV) and vaccinia virus, bacteria including Francisella
tularensis Live Vaccine Strain, F. novicida, Listeria monocytogenes (L. monocytogenes)
and Mycobacterium, and fungi including Aspergillus fumigatus [1]. Of these, F. novicida
is a gram-negative bacterium that exclusively activates AIM2 inflammasome in a type I
IFN signaling-dependent manner in murine macrophages and dendritic cells (Figure 1-2)
[41-43]. After being engulfed in macrophages, F. novicida escapes the Francisellacontaining vacuole and replicates in the cytoplasm. During this process, the cGASSTING pathway senses F. novicida leading to production of type I IFNs [44-46]. Type I
IFNs induces expression of transcriptional factor IRF1 and further IRF1-dependent
expression of immunity-related GTPase family member B10 (IRGB10) and guanylatebinding proteins (GBPs) including GBP2 and GBP5 [44, 45, 47]. IRGB10 and GBPs
belong to a family of IFN-inducible GTPases and are proteins of cell-autonomous
immunity [48]. During F. novicida infection, they are targeted to the cell membrane of
bacteria leading to bacterial killing and release of bacterial ligands including DNA into
the cytoplasm, thereby activating AIM2 inflammasome [44, 45, 47].
While AIM2 is required for host protection against F. novicida infection, the role
of type I IFN signaling during bacterial infection in vivo is diverse, which can be either
beneficial or detrimental depending on the pathogen. Type I IFNs provide protection to
the mice infected with Escherichia coli (E. coli), Streptococcus pneumoniae, or
Streptococcus pyogenes but are deleterious following infection by F. novicida,
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Figure 1-2. Diagram of AIM2 inflammasome in response to F. novicida.
Cytosolic F. novicida is recognized by the cGAS-STING pathway leading to production
of type I IFNs via transcription factors IRF3 and IRF7. Type I IFNs bind to the
heterodimeric receptor consisting of IFNAR1 and IFNAR2 to induce formation of a
signaling transducer named interferon-stimulated gene factor 3 (ISGF3), which include
signal transducer and activator of transcription (STAT) members STAT1, STAT2 and
IRF9 to mediate expression of IRF1 and in turn IRF1-dependent expression of IRGB10
and GBPs. These IFN-inducible GTPases are recruited to the bacteria membrane to
induce bacteriolysis and release of bacterial DNA into the cytosol to activate the AIM2
inflammasome. TheAIM2 inflammasome activates caspase-1. Activated caspase-1
cleaves GSDMD to release the N-terminal portion to induce pyroptosis by generating
pore structures on the cell plasma membrane. Caspase-1 also cleaves pro-IL-1 and proIL-18 into their mature form. IL-1 and IL-18 are released from the cell through the
pores formed by GSDMD.
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Salmonella enterica, or L. monocytogenes [49, 50]. How the interplay between the
opposing effects of both type I IFN signaling and the AIM2 inflammasome determines
the final outcome during host defense against F. novicida infection has remained unclear.
In addition, recent studies have discovered GSDMD as the molecular basis
underlying pyroptosis downstream of inflammasome activation [51-53] (Figure 1-2).
GSDMD belongs to gasdermin family of proteins. Inflammatory caspases including
caspase-11 or caspase-1 cleave a linker region between the N- and C-terminal domain of
GSDMD, releasing the functional N-terminal fragment from inhibition by the C-terminal
end [51-53]. The N-terminal portion of GSDMD has been shown to be associated with
lipid membranes with an ability to directly bind to cardiolipin and phosphoinositides, the
latter of which are usually located in the inner leaflet of the plasma membrane [54-58].
GSDMD forms pores on the membrane and induces cell lysis. In addition, GSDMDformed pores allow release of IL-1 and IL-18 independently of pyroptosis [59, 60].
While IL-1 and IL-18 have been shown to protect against Francisella tularensis Live
Vaccine Strain infection downstream of AIM2 inflammasome activation [61, 62], the role
of AIM2-mediated pyroptosis during Francisella infection has not been studied yet.
Regulation of Inflammasome-Associated Cytokines IL-1 and IL-18
IL-1 and IL-18 are members of the IL-1 cytokine family and are synthesized as
precursor proteins. Upon the assembly of inflammasome, active caspase-1 cleaves IL-1
and IL-18 leading to their subsequent release from the cell [63]. Interestingly, although
IL-1 is not expressed under steady state, a cellular pool of IL-18 already exists before
any inflammatory stimuli, and is ready to be activated and released by the inflammasome
[64]. Expression of IL-1 is induced when cells are stimulated with different toll-like
receptor (TLR) ligands or cytokines [65-67]. Several reports suggest that IL-18
expression can also be induced by several TLR ligands or sendai virus [68-71]. Thus,
how the levels of IL-1 and IL-18 are differentially regulated by inflammatory signals is
unclear.
Summary and Aims of Dissertation
Upon recognition of dsDNA in the cytoplasm, STING mediates expression of
type I IFNs and other inflammatory genes, while AIM2 forms an inflammasome to
induce IL-1 and IL-18 release and pyroptosis. Both DNA-sensing pathways are critical
in infection and autoimmune diseases, while their roles in cancer are yet to be studied.
First two aims of this dissertation is to investigate potential functions of STING and
AIM2 in colon cancer. We hypothesize that they have critical roles during colon cancer
development.
Upon F. novicida infection in vitro, AIM2 senses bacterial DNA derived from F.
novicida to form the inflammasome, a process that is dependent on type I IFN signaling.
However, while the AIM2 inflammasome is protective against F. novicida infection, type
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I IFN signaling is detrimental to the host during the infection in vivo. The third aim of the
dissertation is to address the interplay between AIM2 inflammasome responses and type I
IFN signaling during F. novicida infection in vivo. Thus, we hypothesize that the
detrimental type I IFN signaling could interference with the protective AIM2
inflammasome responses.
The AIM2 inflammasome activates caspase-1 to induce GSDMD-mediated
pyroptosis and release of IL-1 and IL-18. Fourth aim of the dissertation is to study the
role of GSDMD downstream of the AIM2 inflammasome during F. novicida infection.
We hypothesize that GSDMD functions to provide protection to the host during F.
novicida infection.
The fifth aim of the dissertation is to characterize mechanisms governing
expression of IL-1 and IL-18 in response to different inflammatory stimuli.
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CHAPTER 2.

MATERIALS AND METHODS*
Mice

Wide-type (WT) C57BL/6J mice and Irf8tm1.2Hm/J mice (also known as Irf8−/−;
Stock Number 018298) were purchased from The Jackson Laboratory. STING-deficient
(Stinggt/gt) mice [72], Aim2−/− mice [43], Asc−/− mice [73], Casp1−/−Casp11−/− mice [74],
Casp3−/− mice [75], Casp7−/− mice [76], Prom1C-L/+;Ctnnb1lox(ex3)/+ mice [77], Ifnar1−/−
mice [78], Ifnar2−/− mice [79], Irf3−/− mice [80], Irf4fl/fl-Lysm-Cre mice [81], Irf5−/− mice
[81], Irf7−/− mice [82], Irf3−/−Irf7−/− mice [83], Irf5−/− mice [83], Irf9−/− mice [84], Ifnar2–
/–
Aim2–/– mice [83] and Gsdmd−/− mice [85] have been described previously. Stat1−/− mice
were provided by Dr. Abhay Satoskar (Ohio State University). Male and female mice of
6-8 weeks old were used in this study. All mice were bred at the Animal Resource Center
at St. Jude. Animal studies were conducted according to protocols approved by the St.
Jude Animal Care and Use Committee.
Bacterial Culture and Animal Infection
F. novicida strain U112 was grown overnight at 37 °C in BBL Trypticase Soy
Broth (TSB) (BD) contaning 0.2% L-cysteine and were 1:10 subcultured for 4 hours.
Mice were infected subcutaneously with F. novicida in 200 μl PBS. For CFU analysis,
homogenized liver and spleen tissue samples were plated onto TSB agar containing 0.2%
*

Adapted with permission. Zhu Q., Man S.M., Gurung P., Liu Z., Vogel P., Lamkanfi
M., Kanneganti T.D. (2014). Cutting Edge: STING mediates protection against colorectal
tumorigenesis by governing the magnitude of intestinal inflammation. Journal of
Immunology. 193(10):4779-82. Copyright 2014. The American Association of
Immunologists, Inc.
Adapted with open access permission. Man S.M.*, Zhu Q.*, Zhu L.*, Liu Z.*, Karki R.,
Malik A., Sharma D., Li L., Malireddi R.K., Gurung P., Neale G., Olsen S.R., Carter
R.A., McGoldrick D.J., Wu G., Finkelstein D., Vogel P., Gilbertson R.J., Kanneganti
T.D. (2015). Critical role for the DNA sensor AIM2 in stem cell proliferation and cancer.
Cell. 162(1):45-58. (* Co-first author)
Adapted with permission. Zhu, Q. and T.D. Kanneganti, Cutting Edge: Distinct
Regulatory Mechanisms Control Proinflammatory Cytokines IL-18 and IL-1β. J
Immunol, 2017. 198(11): p. 4210-4215. Copyright 2017. The American Association of
Immunologists, Inc.
Adapted with open access permission. Zhu, Q., Man S.M., Karki R., Malireddi R.K.,
Kanneganti, T.D. (2018). Detrimental type I Interferon signaling dominates protective
AIM2 Inflammasome responses during Francisella novicida Infection. Cell Reports. 22,
3168-3174.
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L-cysteine and incubated overnight. For survival analysis following TNF-related
apoptosis-inducing ligand (TRAIL) neutralization, mice were injected intraperitoneally
with 300 mg anti-TRAIL monoclonal antibody (N2B2) or immunoglobulin G2a (IgG2a)
(RTK2758) isotype control (BioLegend) on days 0, 1, and 2 post-infection. For the
recombinant TRAIL (rTRAIL) experiment, mice were injected intraperitoneally with 10
mg rTRAIL (PeproTech) or PBS on the same day as infection.
Induction of Tumors
For azoxymethane (AOM) and dextran sulfate sodium (DSS) model (Figure 2-1)
[86], mice were injected intraperitoneally with 10 mg of AOM (Sigma) per kg body
weight. 5 days later, 3% DSS (molecular mass 36–40 kDa; MP Biologicals) was given in
the drinking water for 6 days, which was further followed by drinking water for 2 weeks.
This cycle was repeated twice with 2.5% DSS. Mice were sacrificed on day 80. For Day
8 samples, mice were injected with AOM, fed 3% DSS for 3 days and sacrificed. For Day
14 samples, mice were injected with AOM, fed 3% DSS for 6 days and sacrificed 3 days
later. For co-housing experiments, equal numbers of female WT and female Aim2−/− mice
were housed in the same cage for 4 weeks. Mice were then housed separately before
AOM injection and remained separated over the course of the experiment. To induce
oncogenic Wnt signaling, tamoxifen induction was performed on 2-month-old mice by
oral gavage with 200 ml tamoxifen (20 mg/ml) in corn oil for 2 days.
LDH Release Assay
Cell culture supernatants were collected at the indicated times, and LDH activity
was measured using the Promega cytotoxicity kit according to manufacturer’s protocols.
Microarray Analysis
Mouse Gene 2.0 (Affymetrix) was used to examine the gene expression profiles
using RNA that was extracted from colon tissues. GSEA software (Broad Institute) was
used to analyze the relevant signaling pathways.
Bone Marrow Chimeras
Mice were subjected to split-dose irradiation, first with a 350 rad dose, followed
by a 950 rad dose 24 hours later. 2 hours after the second dose of irradiation, mice were
injected intravenously with 107 bone marrow cells from the femur and tibia of donor
mice. The following four groups of chimeric mice were generated: WT → WT (CD45.1expressing WT cells into CD45.2-expressing WT mice), Aim2−/− → WT (CD45.2expressing Aim2−/− cells into CD45.1-expressing WT mice), WT → Aim2−/− (CD45.1expressing WT cells into CD45.2- expressing Aim2−/− mice) and Aim2−/− → Aim2−/−
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(CD45.2-expressing Aim2−/− cells into CD45.2-expressing Aim2−/− mice). The
reconstitution rate evaluated 6 weeks after bone marrow transfer was determined by flow
staining of CD45.1 and CD45.2 in blood leukocytes, which was at least 95%.
Histology and Microscopy
Tissues were fixed in 10% formalin, embedded in paraffin and sectioned. Colon
tissues were stained with H&E. The number of proliferating cells in the intestinal
epithelium was detected by immunoperoxidase staining for thymidine analog 5’-bromo2’deoxyuridine (BrdU). In brief, 1 mg/ml BrdU in PBS was injected intraperitoneally.
Colon tissues were collected after 2 hours and fixed in 10% neutral buffered formalin and
embedded in paraffin. Immunohistochemistry was performed using the in situ BrdU
staining kit according to manufacturer’s instructions (BD Bioscience, 550803). Ki67
(NBP1-40684, Novus Biologicals), AKT (4691, Cell Signaling Technology), p-AKT
(Ser473; 4060, Cell Signaling Technology), and c-Myc (5605, Cell Signaling
Technology) staining were performed using antibodies according to the manufacturers’
instructions. The number of Ki67- or BrdU-positive cells per crypt in each animal was
counted (at least 18–20 crypts per mouse) blindly. Tissues were counterstained with
hematoxylin. For staining of goblet cells, colon tissues were stained with PAS and Alcian
blue. The number of goblet cells per crypt was counted blindly. For nLacZ analysis and
GFP microscopy, intestinal tissues were perfused and fixed in 2% paraformaldehyde
overnight, cryo-protected, and frozen in OCT. Sections were stained for -galactosidase
or examined for GFP signal. For -galactosidase staining, frozen sections were washed in
PBS for 5 min and incubated in the dark in standard -galactosidase substrate (5 mM
potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mg/ml X-gal, 2 mM MgCl2,
0.01% sodium deoxycholate, and 0.02% NP-40 in PBS) for 4 hours at 37 °C. Sections
were then rinsed and counterstained by Nuclear Fast Red (Vector, H-3403). For TUNEL
(terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling)
staining of liver tissues after F. novicida infection, the staining was performed using In
Situ Cell Death Detection Kit (11684817910) according to the manufacturer’s
instructions (Sigma).
Histological lesions were scored blindly by a pathologist for following the
categories: inflammation severity, ulceration, hyperplasia and lesion area. Inflammation
severity was assigned as follows: 0 = normal; 1 = mild (small, focal, or widely separated,
mostly limited to lamina propria); 2 = moderate (multifocal mucosal inflammation, often
extending to submucosa); 3 = marked (multifocal and coalescing to extensive
inflammation with occasional transmural foci); 4 = severe (diffuse inflammation with
transmural inflammation). Scores for ulceration were assigned as follows: 0 = normal (no
ulcers); 1 = mild (1–2 ulcers, involving up to a total of 20 crypts); 2 = moderate (1–4
ulcers, involving a total of 20–40 crypts); 3 = severe (more than 4 ulcers or over 40
crypts). Hyperplasia scores were assigned as follows: 0 = normal; 1 = mild (Crypts
elongated, normal epithelium); 2 = moderate (Crypts elongated with crowding of
hyperchromatic epithelium, no branching of crypts); 3 = marked (Crypts 2-3 times
normal thickness, hyperchromatic epithelium, reduced goblet cells, scattered
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arborization); 4 = severe (Crypts 2-3 times normal thickness, marked hyperchromasia,
few to no goblet cells, high mitotic index, frequent arborization). Scoring for lesion areas
were assigned as follows: 0 = normal (0% involvement); 1 = minimal (less than 10%
involvement); 2 = mild (10% to 25% involvement); 3 = moderate (25% to 50%
involvement); 4 = marked (50% to 75% involvement); 5 = severe (over 75%
involvement).
Cell Culture and Stimulation
Bone marrow-derived macrophages (BMDMs) were cultured for 6 days in
DMEM containing 10% FBS, 30% L929 conditioned media and 1% penicillin and
streptomycin, and seeded at a concentration of 1 × 106 cells onto 12-well plates. The next
day, BMDMs were incubated in antibiotic–free media. BMDMs were stimulated with
LPS (500 ng/mL; InvivoGen), Pam3CSK4 (1 μg/mL), gardiquimod (1 μg/mL;
InvivoGen), Poly(I:C) (10 μg/mL; InvivoGen), or IFNβ (400 U/mL; PBL Assay Science).
For transfection of poly(dA:dT), 0.25 μg or 1 ug of poly(dA:dT) (InvivoGen) was mixed
with 0.3 mL of Xfect polymer in Xfect reaction buffer (Clontech Laboratories) for 10
min and then added to BMDMs in Opti-MEM (ThermoFisher Scientific). For transfection
of cGAMP, 1 μg of cGAMP (InvivoGen) was mixed with 0.3 mL of Xfect polymer in
Xfect reaction buffer (Clontech Laboratories) for 10 min and then added to BMDMs in
Opti-MEM (ThermoFisher Scientific). F. novicida was cultured and added to unprimed
BMDMs at an indicated MOI for 20 hours. 50 μg/ml gentamicin was added after 4 hours
of the infection. The MCMV Smith MSGV strain (VR-1399, American Type Culture
Collection) was obtained from P.G. Thomas (St. Jude) and was used in experiments in
Chapter 5. The MCMV strain (K181) was obtained from Edward S. Mocarski (Emory
University School of Medicine) [87] and was used in experiments in Chapter 6. MCMV
was added at an MOI of 10 for 10 hours.
Cytokine Analysis
Levels of cytokines were measured by ELISA according to the manufacturer’s
instructions (IL-18 ELISA from eBioscience, IFN-β from BioLegend and all other
cytokines were from Millipore).
Immunoblotting Analysis
Proteins from tissues were extracted using RIPA buffer supplemented with
protease and phosphatase inhibitors (Roche). BMDMs samples were prepared as
previously described [81, 83]. Prepared samples were then separated by SDS-PAGE and
transferred to polyvinylidene difluoride membranes (Millipore). Membranes were
blocked by 5% milk and incubated with primary antibodies overnight. The primary
antibodies used were, caspase-1 p10 (sc-515, Santa Cruz), p-ERK (9101, Cell Signaling
Technology), ERK (9102, Cell Signaling Technology), p-IBa (9241, Cell Signaling
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Technology), IBa (9242, Cell Signaling Technology), STAT3 (9139, Cell Signaling
Technology), p-STAT3 (9131, Cell Signaling Technology), HIF-1 (3716, Cell
Signaling Technology), p-AKT Ser473 (9271, Cell Signaling Technology), AKT (4691,
Cell Signaling Technology), p-PTEN (9554, Cell Signaling Technology), PTEN (9552,
Cell Signaling Technology), c-Myc (5605, Cell Signaling Technology), caspase-1 (AG20B-0042, Adipogen), caspase-8 (ALX-804-447-C100, Enzo Life Sciences), cleaved
caspase-8 (8592, Cell Signaling Technology), caspase-3 (9662, Cell Signaling
Technology), cleaved caspase-3 (9661, Cell Signaling Technology), caspase-7 (9492,
Cell Signaling Technology), cleaved caspase-7 (9491, Cell Signaling Technology),
TRAIL (AF1121, R&D Systems), DR5 (MAB1540, R&D Systems), GAPDH (5174, Cell
Signaling Technology), GSDMD (ab209845, Abcam), IL-18 (D046-3, MBL
International), IL-1β (AF-401-NA, R&D Systems), and β-actin (8457, Cell Signaling
Technology). Membranes were then incubated with HRP-conjugated secondary antibody
for 1 hour and proteins were visualized using ECL substrate (ThermoScientific) or
Luminata Forte Western HRP substrate (Millipore). Immunoblots were quantified using
ImageJ in Chapter 5.
Colon Organoid Culture
Mouse colon stem cells were cultured as previously described with modifications
[88]. Briefly, mice were perfused with prewarmed 30 mM EDTA in PBS. The colon was
removed and rinsed with PBS. Colonic mucosa was scraped from the muscle layer and
kept in 10 mM EDTA in PBS on ice and incubated in a shaker at 350 RPM for 15 min at
4 °C. Dissociated colonic crypts were vigorously suspended. Cells were filtered through a
70 mm cell strainer, mixed with Matrigel (BD Bioscience, 354230) and plated in 60 mm
plates. The culture medium consisted of Advanced DMEM/F12 supplemented with B27,
N2, N-Acetylcysteine, Gastrin (10 nM), and growth factors, including 50 ng/ml EGF, 1
mg/ml R-spondin1, 100 ng/ml Noggin, 100 ng/ml FGF10, and Wnt3A conditioned media
[89].
Real-time Quantitative PCR
RNA was extracted using TRIzol reagent (Life Technologies). Isolated RNA was
reverse transcribed into cDNA using the First-Strand cDNA Synthesis Kit (Life
Technologies). Real-time quantitative PCR (qPCR) was performed on an ABI 7500 realtime PCR instrument with 2× SYBR Green (Applied Biosystems). Primer sequences in
Table 2-1.
Universal Sequencing of Gut Microbiota
Genomic DNA from feces was extracted with the QiAamp DNA stool Mini Kit
(QIAGEN) and used for 16S rRNA gene sequencing. Libraries were prepared by
amplification of the 16S v4 domain according to the manufacturer’s instructions (Bioo

12

Table 2-1.
Target
Sting
Aim2
Gapdh
Il17a
Il22
Il23p19
Ifnb
Ifng
Tgfb1
Tgfb2
Il10
Muc2
Muc3
Muc4
cMyc
S100a9
Snrpd1
Dbf4
Il18
Il1b
Trail
Dr5

Real-time qPCR primer sequences.
Primer sequence
Forward: 5’-CAT TGG GTA CTT GCG GTT-3’
Reverse: 5’-CTG AGC ATG TTG TTA TGT AGC-3’
Forward: 5’-GAT TCA AAG TGC AGG TGC GG-3’
Reverse: 5’-TCT GAG GCT TAG CTT GAG GAC-3’
Forward: 5’-CGT CCC GTA GAC AAA ATG GT-3’
Reverse: 5’-TTG ATG GCA ACA ATC TCC AC-3’
Forward: 5’-TCC AGA AGG CCC TCA GAC TA-3’
Reverse: 5’-ACA CCC ACC AGC ATC TTC TC-3’
Forward: 5’-TCC GAG GAG TCA GTG CTA AA-3’
Reverse: 5’-AGA ACG TCT TCC AGG GTG AA-3’
Forward: 5’-GGT GGC TCA GGG AAA TGT-3’
Reverse: 5’-GAC AGA GCA GGC AGG TAC AG-3’
Forward: 5’-GCC TTT GCC ATC CAA GAG ATG C-3’
Reverse: 5’-ACA CTG TCT GCT GGT GGA GTT C-3’
Forward: 5’-GCA TCT TGG CTT TGC AGC T-3’
Reverse: 5’-CCT TTT TCG CCT TGC TGT TG-3’
Forward: 5’-CTC CCG TGG CTT CTA GTG C-3’
Reverse: 5’-GCC TTA GTT TGG ACA GGA TCT G-3’
Forward: 5’-TCG ACA TGG ATC AGT TTA TGC G-3’
Reverse: 5’-CCC TGG TAC TGT TGT AGA TGG A-3’
Forward: 5’-GCT CTT ACT GAC TGG CAT GAG-3’
Reverse: 5’-CGC AGC TCT AGG AGC ATG TG-3’
Forward: 5’-GCT GAC GAG TGG TTG GTG AAT G-3’
Reverse: 5’-GAT GAG GTG GCA GAC AGG AGA C-3’
Forward: 5’-CGT GGT CAA CTG CGA GAA TGG-3’
Reverse: 5’-CGG CTC TAT CTC TAC GCT CTC C-3’
Forward: 5’-CAG CAG CCA GTG GGG ACA G-3’
Reverse: 5’-CTC AGA CAC AGC CAG GGA ACT C-3’
Forward: 5’-TCT CCA CTC ACC AGC ACA ACT ACG-3’
Reverse: 5’-ATC TGC TTC AGG ACC CT-3’
Forward: 5’-GGT GGA AGC ACA GTT GGC A-3’
Reverse: 5’-GTG TCC AGG TCC TCC ATG ATG-3’
Forward: 5’-CAG CAT GAA CAC ACA CCT TAA AG-3’
Reverse: 5’-GCC TCG AAT ACT CAA TGT TTC CA-3’
Forward: 5’-AAT AAG ATA CAG TGT CGG GTC CC-3’
Reverse: 5’- GTC CTT CTG GAA ATT GGG CTC-3’
Forward: 5’-GCC TCA AAC CTT CCA AAT CA-3’
Reverse: 5’-TGG ATC CAT TTC CTC AAA GG-3’
Forward: 5’-GAC CTT CCA GGA TGA GGA CA-3’
Reverse: 5’-AGC TCA TAT GGG TCC GAC AG-3’
Forward: 5’- ACC TCA GCT TCA GTC AGC ACT TC -3’
Reverse: 5’- TGT AAG TCA CAG CCA CAG ACA CAG -3’
Forward: 5’- AGT GTG TCT CCA AAA CGG -3’
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Table 2-1.
Target
b-actin
Hprt

Continued.
Primer sequence
Reverse: 5’- AAT GCA CAG AGT TCG CAC T -3’
Forward: 5’-CAG CTT CTT TGC AGC TCC TT-3’
Reverse: 5’-CAC GAT GGA GGG GAA TAC AG-3’
Forward: 5’-CTC ATG GAC TGA TTA TGG ACA GGA C-3’
Reverse: 5’-GCA GGT CAG CAA AGA ACT TAT AGC C-3’
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Scientific Corporation). Paired-end 150 cycle sequencing was performed on a MiSeq
using 300 cycle v2 sequencing kits according the manufacturer’s instructions (Illumina)
with the following modifications: a phiX library was spiked in at ~10%, and library
specific sequencing primers were added to the Illumina primer wells as specified by the
manufacturer (Bioo Scientific Corporation). Primers targeting the 16S V4 region were
aligned to the full set of sequences from the Greengenes database v13.5 [90] using
exonerate [91]. Each sequence was truncated to include only the V4 region, the primermatching regions and an additional 40 bases on either side. Duplicate V4 regions were
removed from the dataset. All taxa labels from the removed duplicates were associated
with the remaining representative V4 region sequence. Reads from each sample were
aligned exhaustively to the non-redundant V4 sequences using USEARCH [92] allowing
a minimum sequence identity of 90%. All taxon labels associated with the top-scoring V4
region(s) were used to determine the taxon assignment of each read. The highest
resolution non-conflicting taxon from all taxa associated with the top-scoring V4 region
was assigned as the taxa for a read. Relative proportions of microbial taxa for each
sample were assembled from the highest resolution sequence counts into a matrix with
samples as columns and taxa as rows with proportions in cells. Columns were also
assigned to either a WT or Aim2−/− group. All relative proportions were transformed to
near normality with a shifted logit-p transformation [86]. Unpaired T-test with unequal
variance for the normalized proportions and a two-factor ANOVA model was used to
investigate significant taxa. Transformed values were then normalized for each taxa to
produce a signal to noise ratio [86]. Signal to noise ratios are depicted in a heatmap plot
and Principal Component Analysis (PCA) were generated with Spotfire (Tibco software
Inc).
IncuCyte Analysis
BMDMs were seeded at a concentration of 1 × 106 cells onto 12-well plates. The
next day, BMDMs were stimulated and incubated with 100 nM of cell-impermeable
DNA-binding fluorescent dye Sytox Green (S7020, Life Technologies) to stain dead
cells. Cell death was monitored in real-time using a two-color IncuCyte Zoom inincubator imaging system (Essen Biosciences). Nuclear-ID (ENZ-52406, Enzo Life
Sciences) was added at the last time point to stain live and dead cells for the total cell
number [93]. Resulting images were analyzed using IncuCyte S3 software. Cell death
was presented as a percentage of Sytox Green+ cells to the total cell number. Experiments
were conducted with three replicates for each experimental condition and nine image
fields per well.
Flow Cytometry
For intracellular cytokine staining, cells were processed as previously described
[94]. The following monoclonal antibodies were diluted 1:300 and used for flow
cytometry cellular analyses: CD3 (17A2), CD4 (RM4-5), CD11b (M1/70), CD19 (1D3),
CD8a (53-6.7), IFN-γ (XMG1.2) and IL-17A (eBio17B7) from eBioscience, CD4
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(GK1.5), TCR-β (H57-597), CD11c (N418), Gr1 (RB6-815), F4/80 (BM8), IL-6 (MP520F3) and TNF (MP6-XT22) from BioLegend and CD8a (53-6.7) from Sony. Flow
cytometry data were acquired on FACSCalibur (BD) and were analyzed with FlowJo
software (FlowJo, LLC and Illumina, Inc).
Statistical Analysis
GraphPad Prism software was used for data analysis. Data are shown as mean ±
SEM. Statistical significance was determined by performing t tests (two-tailed), one-way
ANOVA or log-rank test. P<0.05 was considered to be statistically significant where *p <
0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

16

CHAPTER 3.

STING MEDIATES PROTECTION AGASINT COLON CANCER
BY REGULATING COLON INFLAMMATION
Introduction

Colon cancer is the third most common malignant tumor in the United States,
with 1.5 million new cases being diagnosed each year [95]. Clinical studies have shown
that patients diagnosed with inflammatory bowel diseases have a greater risk of
developing colon cancer compared to healthy individuals [96]. Pattern recognition
receptors are key initiators of inflammation, which have been shown to be involved in
colitis-associated colon cancer development [97].
Cytosolic nucleic acid receptors mediate the detection of DNA and RNA
molecules within the cell and provide robust host immune defense against intracellular
pathogens and protection against autoimmune diseases [98]. STING is a cytoplasmic
receptor for cyclic dinucleotides and an adaptor for other DNA sensors [12, 15, 17, 19,
99, 100]. The upstream DNA sensors, which signal through STING include cGAS, IFI16
and DDX41 [12, 99, 100], highlighting an important function for STING in governing
multiple DNA recognition pathways. STING recruits TBK1 to activate IRF3, the latter of
which translocates into the nucleus in a dimeric form and induces transcription of type I
interferons.
Since its discovery, STING has been shown to contribute to the host defense
against viral, bacterial and eukaryotic pathogens [101]. Whether STING plays a role
during the development of colon cancer or other types of cancer is unknown. Evidence
for a role of a number of nucleic acid sensors in tumorigenesis is emerging. Our group
and others have previously shown that nucleotide-binding domain, leucine-rich repeat
containing protein 3 (NLRP3), a proposed sensor of RNA or DNA:RNA hybrid in the
cytoplasm of a cell [102-104], mediates protection against colon cancer development by
modulating IL-18 production [27, 29]. The double-stranded DNA sensor, AIM2, and the
double-stranded RNA sensor, RIG-I, are downregulated in patients with colorectal cancer
and hepatocellular carcinoma, respectively, and reduced expression of these proteins are
associated with increased mortality in these patients [26, 105]. Expression of LGP2, a
negative regulator of RIG-I, promotes the survival of colon tumor and other cancer cell
lines [106]. In addition, mice lacking the DNA sensor, Ku70, in combination with the
p53R172P mutation, develop spontaneous colonic inflammation and colon cancer [107].
These studies indicate that nucleic acid sensors may play a critical function in the
regulation of tumorigenesis.



Adapted with permission. Zhu Q., Man S.M., Gurung P., Liu Z., Vogel P., Lamkanfi
M., Kanneganti T.D. (2014). Cutting Edge: STING mediates protection against colorectal
tumorigenesis by governing the magnitude of intestinal inflammation. Journal of
Immunology. 193(10):4779-82. Copyright 2014. The American Association of
Immunologists, Inc.
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In this study, we show that STING-deficient mice (Stinggt/gt) are highly
susceptible to tumor formation in a model of colitis-associated colorectal cancer. The
absence of STING leads to excessive colon inflammation during early stages of tumor
development, characterized by elevated levels of colonic and circulating proinflammatory cytokines and an increased number of proliferative intestinal epithelial
cells. In addition, we observe increased phosphorylation of NF-κB and STAT3 in
STING-deficient mice, indicating a role for STING in governing the suppression of
transcription factor activities during intestinal inflammation. Overall, these results
underscore a critical role for STING in mediating host protection against colorectal
tumorigenesis.
Results and Discussion
STING is expressed in a variety of tissues and organs in mice (Figure 3-1A). The
spleen and small and large intestines expressed the highest levels of STING mRNA
(Figure 3-1A). To investigate the role of STING in colon tumor development, we
utilized a colitis-associated colon cancer model to induce colon tumorigenesis in mice.
We intraperitoneally injected AOM into WT and Stinggt/gt mice followed by three rounds
of DSS treatment. After 80 days post-AOM injection, we observed that Stinggt/gt mice had
significantly increased tumor burden compared to WT controls (Figure 3-1B–C).
Although the number of tumors doubled in Stinggt/gt mice, the size of tumors in Stinggt/gt
and WT mice was similar (Figure 3-1D). Histological analysis revealed that Stinggt/gt
mice exhibited more severe pathological damage after tumor development, characterized
by increased colonic inflammation and hyperplasia (Figure 3-1E–G). Histological
observations were quantified and these scores revealed that Stinggt/gt mice showed
enhanced intestinal pathology compared to WT mice (histological scores: 17.6 ±1.2 for
Stinggt/gt and 10.6 ± 0.9 for WT; Figure 3-1F). Notably, the incidence of dysplasia was
observed exclusively in Stinggt/gt mice, with 75% of the colon samples from Stinggt/gt mice
showing hallmarks of low grade (50% of the samples) or high grade (25%) dysplasia
(Figure 3-1H). Therefore, these data suggest a crucial role for STING in suppressing
colorectal tumorigenesis in colitis-associated colon cancer.
We observed that Stinggt/gt mice lost significantly more body weight than WT
mice (Figure 3-2A). Indeed, the colon length was greatly reduced in Stinggt/gt mice on
Day 14 (Figure 3-2B). H&E staining revealed an increase in cellular infiltration, crypt
thickness and hyperchromatin in colon tissues of Stinggt/gt mice on Day 14 (Figure 3-2C).
In agreement, all of the histologic parameters assessed – inflammation, ulceration and
hyperplasia – were significantly higher in Stinggt/gt mice compared to WT mice
(Figure 3-2D–E). To assess whether STING mediates neoplastic changes that predispose
the host to increased tumorigenic events, we performed Ki-67 staining on colon tissue
sections and quantified the magnitude of intestinal epithelial proliferation. In line with
our histological analysis, the colon of Stinggt/gt mice had significantly increased numbers
of Ki-67 positive cells per crypt (58.7 ± 2.1; n=137) compared to WT mice (39.6 ± 1.3;
n=153; P<0.0001) on Day 14 (Figure 3-2F). Taken together, these results suggest that
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Figure 3-1. STING is critical for mediating protection against colon tumor
development.
(A) Relative Sting mRNA levels in different tissues of WT mice. (B) Colons from WT
and Stinggt/gt mice on Day 80 post-AOM injection. (C) Tumor number and (D) size in WT
and Stinggt/gt mice. (E) Colon tissue sections by H&E staining. Magnification: 20×. (F)
Total histological scores and (G) scores for different parameters on Day 80. (H)
Percentage of WT and Stinggt/gt mice with dysplasia. *p<0.05; **p<0.01; ***p<0.001;
****p<0.0001. (two-tailed t test [B–D, F, and G]). Data are from one experiment
representative of three independent experiment (B and D–H) or pooled from three
independent experiments (A and C; mean and SEM in C, D, F and G).
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Figure 3-2. STING dampens early intestinal damage and overt proliferation.
(A) Body weight changes in WT and Stinggt/gt mice during early stages of colorectal
tumorigenesis. (B) Colon length on Day 14 post-AOM injection. (C) H&E staining of
colon tissue sections on Day 14. Magnification: 10×. (D) Total histological scores and
(E) scores for different parameters on Day 14. (F) The number of Ki-67-positive cells in
each crypt of each animal on Day 14 (at least 27 crypts per mouse). WT n=5; Stinggt/gt
n=5. Data are mean ± SEM of two independent experiments. NS, not statistically
significant; **p<0.01; ***p<0.001; ****p<0.0001. (two-tailed t test [A, B, D, E and F]).
Data are from one experiment representative of two independent experiment (C, D, E and
F) or pooled from two independent experiments (A and B; mean and SEM in A, B, D, E
and F).
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STING plays an important function in controlling disease initiation and susceptibility to
hyper-proliferation during early stages of colitis-associated colon cancer.
Since inflammation is one of the most important drivers in the development of
colon cancer [97], we hypothesized that STING is controlling inflammation during early
stages of AOM-DSS treatment, which ultimately determines host susceptibility to
colorectal tumorigenesis. To analyze the magnitude of colonic inflammation in Stinggt/gt
mice, we measured levels of the pro-inflammatory cytokines IL-6 and CXCL1 (KC) on
Day 14 post-AOM injection. We observed a significant increase in the levels of IL-6 and
KC in colon tissues of Stinggt/gt mice compared to WT mice (Figure 3-3A). We
confirmed this finding and observed elevated levels of circulating IL-6 and KC in the
serum of Stinggt/gt mice (Figure 3-3B). Consistently, we found elevated phosphorylation
of ERK and IκBα in colon tissues of Stinggt/gt mice compared to WT mice on Day 14
(Figure 3-3C). Previous reports have shown that myeloid cell-derived IL-6 signals
through IL-6R and gp130 to activate cytoplasmic STAT3 in intestinal epithelial cells
[108, 109]. STAT3 is frequently activated in pre-malignant and cancer cells to promote
colon tumorigenesis by amplifying inflammation and tumorigenic transformation [110].
Indeed, colon tissues from Stinggt/gt mice showed increased STAT3 phosphorylation
compared to WT mice (Figure 3-3D). We also measured production of type I IFN by
testing the level of IFN-β after 14 days post-AOM injection and detected only basal
levels of IFN-β in colon tissues from WT or Stinggt/gt mice (Figure 3-4A).
Caspase-1-mediated release of IL-18 following inflammasome activation has been
shown to play a protective role in preventing AOM-DSS-induced colitis and colitisassociated colorectal tumorigenesis [27-29, 111]. Mice lacking caspase-1 or IL-18
exhibited elevated tumor burden in the colon with increased levels of pro-inflammatory
cytokines during AOM-DSS-induced colon tumorigenesis [29]. We found reduced levels
of caspase-1 activation and IL-18 release in colon tissues of Stinggt/gt mice compared to
WT mice after 14 days (Figure 3-4B–C). Therefore, it is possible that the crosstalk
between STING and caspase-1 could mediate protection against colon tumorigenesis at
the intestinal barrier. Indeed, recent studies suggest that activation of the STING pathway
leads to assembly of NLRP3 inflammasome [112, 113], potentially by inducing
lysosomal cell death and potassium efflux [112]. It is possible that STING induces
NLRP3 inflammasome activation in the colon leading to caspase-1-mediated protective
IL-18 release. These findings highlight that STING restricts NF-κB and STAT3 signaling
pathways by activating inflammasome responses to control colon inflammation and
tumorigenesis.
The gut microbiota plays a critical role in modulating susceptibility to colorectal
cancer. Dysbiosis is associated with increased susceptibility to colitis and colon cancer
development [97]. To investigate whether an altered gut microbiota profile contributed to
the elevated incidence of colorectal tumorigenesis in Stinggt/gt mice, we performed realtime qPCR analysis to detect the abundance of five major intestinal bacterial populations
from WT and Stinggt/gt mice. We found that WT and Stinggt/gt mice harbored similar levels
of Prevatollaceae, Bacteroides, mouse intestinal Bacteroides (MIB), segmented
filamentous bacteria (SFB) and TM7 (Figure 3-4D–H). Therefore, it is unlikely that
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Figure 3-3. STING suppresses overt colon inflammation during tumor
development.
(A and B) Levels of IL-6 and KC in colon tissues (A) and serum (B) on Day 14 postAOM injection. (C and D) Phosphorylation of ERK, IκBa (C) and STAT3 (D) in colon
tissues on Day 14, quantified by densitometric analysis. Data are mean ± SEM of two
independent experiments. *p<0.05; **p<0.01; ***p<0.001. (two-tailed t test [A and B]).
Data are from one experiment representative of two independent experiment (C and D) or
pooled from two independent experiments (A and B; mean and SEM in A–D).
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Figure 3-4. The type I IFNs, caspase-1 and gut microbiota profile of WT and
Stinggt/gt mice.
(A) Levels of IFN-β in colon tissues from WT and Stinggt/gt mice after 14 days post-AOM
injection were measured by ELISA. (B) Caspase-1 cleavage in colon lysates from WT
and Stinggt/gt mice on Day 14. (C) Level of IL-18 in colon tissues on Day 14. (D–H)
Levels of Prevatollaceae, Bacteroides, MIB, SFB and TM7 in untreated WT and Stinggt/gt
mice. Data are shown as mean ± SEM of two independent experiments. NS, not
statistically significant; ***p<0.001.
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differences in these bacterial populations contributed to the protective role of STING
during colon cancer development.
During AOM-DSS-induced colon tumorigenesis, STING itself or in concert with
an upstream DNA sensor may recognize either cytosolic DNA in tumor cells, or DNA
upon DNA damage [114], or DNA derived from dying cells during intestinal barrier
damage or colon tumor cells [115]. In addition, oxidative DNA damage has been shown
to accumulate in intestinal epithelial cells and activate STING signaling [116, 117]. It is
possible that recognition of self-DNA by STING mediates inflammasome activation,
which suppresses colon inflammation and reduces the likelihood of uncontrolled
inflammation leading to tumorigenesis.
Overall, our results underscore a novel role for STING in modulating activation
of NF-κB and STAT3 signaling and production of IL-18 during the development of colon
cancer. These inflammatory mediators may modulate the tumorigenic properties of
intestinal cells, which ultimately regulate proliferation and tumorigenesis. Collectively,
our data indicate that STING plays a critical role in mediating protection against
inflammation-associated colon cancer development. Therapeutic modulation of STING in
susceptible individuals may have the potential to prevent and treat colon cancer.
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CHAPTER 4.

ROLE OF THE DNA SENSOR AIM2 IN COLON CANCER
Introduction

Colorectal cancer is a leading cause of cancer-related deaths, with 160,000 cases
being diagnosed annually in the USA [118]. Mutations in the gene encoding AIM2 are
frequently identified in patients with colorectal cancer. A previous study has shown that
over 50% of tumors from patients with small bowel cancer have frameshift mutations in
the gene encoding AIM2 [119]. Further genetic evidence has shown that frameshift and
missense mutations are targeted to the coding regions of the gene encoding AIM2 in
colon cancer tissues and cell lines [38, 39]. These include frameshift mutations in the
A10 repeat of exon 6, a deletion mutation in the A6 repeat of exon 5, and a
nonsynonymous nucleotide exchange within exon 2 of the gene encoding AIM2 – all of
which were identified in tumor tissues of patients with colorectal cancer with a high level
of microsatellite instability associated with deficiency in mismatch repair [38]. Analysis
of 414 colorectal tumors and matching control tissues further revealed that 67% of the
tumors displayed reduced expression of the gene encoding AIM2 relative to control
tissues [26]. Nearly 50% of patients who completely lacked expression of the gene
encoding AIM2 in their tumor cells die from their cancer within five years of diagnosis,
whereas over 70% of patients whose tumor cells retained some expression survived
beyond five years after their diagnosis [26]. A better understanding of the biological
function of AIM2 in colorectal cancer is key to identifying therapies that could be used in
the treatment of this disease.
AIM2 is a cytosolic dsDNA receptor which contributes to the host defense against
bacterial and viral pathogens, such as Francisella tularensis and vaccinia virus,
respectively [32-35, 41, 42]. We previously identified that infection by the cytosolic
bacterium F. novicida activates the transcription factor IRF1, which induces production
of interferon-inducible GTPases called GBPs [44]. GBPs attack and kill bacteria in the
cytoplasm, resulting in the liberation of bacterial DNA for recognition by AIM2 [44, 45].
Upon binding of dsDNA in the cytoplasm of infected cells, AIM2 recruits the adaptor
protein ASC to assemble an inflammasome complex that activates caspase-1, a cysteine
protease that induces pyroptosis and mediates the cleavage of the inflammatory cytokines
IL-1 and IL-18. Structural analysis of AIM2 revealed that the HIN200 domain binds
dsDNA, whereas the pyrin domain recruits ASC [120]. DNA accumulated in
keratinocytes also activates the AIM2 inflammasome to drive the release of IL-1β in
lesions of patients with psoriasis [121], suggesting that AIM2 has the capacity to
recognize damage-associated molecular patterns released by the cell. Activation of AIM2
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must, therefore, be tightly regulated to allow clearance of pathogens while maintaining
homeostasis to prevent the development of autoimmune conditions.
In this study, we found that AIM2-deficient (Aim2–/–) mice developed more
tumors in the colon following AOM and DSS-induced colitis-associated tumorigenesis.
Unlike its role in the host defense against infection, AIM2 protected against
tumorigenesis by controlling intestinal epithelial cell proliferation via a mechanism
independent of inflammasomes and inflammatory mediators. Upon dyregulated Wnt
signaling, AIM2 suppressed expansion of tumor-initiating intestinal stem cells lining the
base of the crypt. Remarkably, reciprocal exchange of the gut microbiota between healthy
WT mice and Aim2–/– mice reduced the susceptibility of Aim2–/– mice to colorectal
tumorigenesis. These findings revealed a role for AIM2 and its synergy with gut
microbiota in the development of colorectal cancer.
Results
The DNA Receptor AIM2 Is Required to Prevent Colorectal Cancer
Mutations in the gene encoding AIM2 are associated with colorectal cancer and
reduced expression of this gene is linked to increased mortality in humans [122-125]. In
mice, the gene encoding AIM2 was widely expressed in the intestine, especially in the
colon (Figure 4-1A), which suggested a role for AIM2 in regulating homeostasis in the
gastrointestinal tract. To investigate the role of AIM2 in colorectal cancer, we used an
established model of colitis-associated colorectal tumorigenesis whereby mice were
injected intraperitoneally with AOM, followed by three rounds of DSS treatment
(Figure 2-1). Expression of the gene encoding AIM2 was drastically reduced in the colon
of WT mice 14 or 80 days after injection of AOM (Figure 4-1B–C).
We treated cohorts of WT and Aim2–/– mice with AOM followed by DSS and
examined the development of colon tumors after 80 days. We found that Aim2–/– mice
developed significantly increased numbers and size of tumors throughout the middle and
distal colon compared with WT mice (Figure 4-1D–F). Aim2–/– mice also tended to lose
more body weight over the course of DSS treatment after injection of AOM
(Figure 4-1G). Histopathological analysis revealed that Aim2–/– mice exhibited increased
hyperplasia in the proximal, middle and distal colon (Figure 4-1H). Low-grade dysplasia
was restricted to tumor-bearing WT mice whereas both low- and high-grade dysplasia
was observed in Aim2–/– mice (Figure 4-1I–J). These results suggested that AIM2
mediated protection against colorectal tumorigenesis.
AIM2 Controls Tumor Development Independently of Inflammasomes
AIM2 is a dsDNA receptor that contributes to the host defense against bacterial
and viral pathogens by inducing inflammasome responses, including the production of
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Figure 4-1. AIM2 prevents colitis-associated colorectal tumorigenesis.
(A) Relative expression of the gene encoding AIM2 in tissues of WT mice. (B) Relative
expression of the gene encoding AIM2 in colon tissues of untreated WT mice or WT
mice 14 days after injection of AOM. (C) Relative expression of the gene encoding
AIM2 in colon tissues of untreated WT mice or WT mice 80 days after injection of
AOM. (D) Colon tumors in WT and Aim2–/– mice 80 days after injection of AOM. (E and
F) Number and size of colon tumors in WT (n = 34) and Aim2–/– (n = 27) mice. (G) Body
weight change of mice pooled from six independent experiments. (H) Histological scores
80 days after injection of AOM. (I) Percentages of mice with dysplasia 80 days after
injection of AOM. (J) H&E staining of colon tumors. Original magnification, 10. *p <
0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; NS, not statistically significant (twotailed t test [B, C, E, F, and H] or one-way ANOVA [G]). Data are from two (A–C) or six
independent experiments (D–J; mean and SEM in B, C, E, F, G, and H).
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IL-18. We and others have previously shown that IL-18 induced by the related
inflammasomes, NLRP3 or PYRIN inflammasome, is required for protection against
colitis and colitis-associated tumorigenesis [27-29, 111]. To investigate the molecular
mechanism underpinning AIM2-dependent protection against colorectal tumorigenesis,
we first examined whether there was a lack of inflammasome signaling in Aim2–/– mice
that could be responsible for their increased susceptibility to tumorigenesis. We analyzed
the levels of caspase-1 processing in the colon of WT and Aim2–/– mice and found similar
levels of caspase-1 activation 14 days after injection of AOM (Figure 4-2A). We also
detected similar levels of IL-18 in the colon tissues and serum of untreated WT and
Aim2–/– mice or in WT and Aim2–/– mice 8, 14 or 80 days after injection of AOM
(Figure 4-2B). To further confirm these results, we measured IL-1β and found similar
levels of this inflammasome-dependent cytokine in the colon tissues of untreated WT and
Aim2–/– mice or in WT and Aim2–/– mice 14 or 80 days after injection of AOM
(Figure 4-2C).
Although AIM2 functioned independently of the inflammasome in protection
against colonic tumorigenesis, we investigated whether other inflammatory mediators
might be playing a role in the absence of AIM2 that could have accelerated the
progression of colorectal cancer. Shortening of the colon during DSS treatment is a
hallmark of inflammation. However, we observed similar colon lengths in WT and Aim2–
/–
mice 14 or 80 days after injection of AOM (Figure 4-2D). The NF-κB pathway is a
major driver of inflammation. To this end, we analyzed phosphorylation of ERK and
IκBα in colon tissues of WT and Aim2–/– mice following AOM-DSS treatment. Both
groups of mice exhibited similar levels of phosphorylated ERK and IκBα (Figure 4-2E).
In agreement, the levels of pro-inflammatory cytokines IL-6, TNF and G-CSF and the
chemokine KC were not significantly increased in Aim2–/– mice 14 days after injection of
AOM when compared with WT mice (Figure 4-2F). However, an increase in the levels
of TNF, G-CSF and KC were observed 80 days after injection of AOM (Figure 4-2F).
We further assessed the levels of cytokines IL-22, IL-23p19, IFN-β, IFN-γ and IL-17A.
Using qRT-PCR analysis, we found that the expression of genes encoding these
cytokines was similar in colon tissues of untreated WT and Aim2–/– mice and in colon
tissues of WT and Aim2–/– mice 14 days after injection of AOM (Figure 4-3A–B).
However, Aim2–/– mice had an increase in the expression of the gene encoding IL-10 14
days after injection of AOM (Figure 4-3C). Furthermore, we found that the expression of
genes encoding TGF-β1 and TGF-β2 was similar in colon tissues of untreated WT and
Aim2–/– mice and in WT and Aim2–/– mice 14 days after injection of AOM (Figure 4-3C).
We used an automated hematology analyzer to determine the number and influx
of circulating white blood cells from the peripheral blood of WT and Aim2−/− mice. We
observed similar levels of neutrophils, lymphocytes, monocytes, eosinophils and
basophils and total white blood cells in the blood of WT and Aim2−/− mice 14 or 80 days
after injection of AOM (Figure 4-3D). While there was an increase in circulating
lymphocytes in Aim2−/− mice on day 80 compared with day 14, the proportion of IFN-γ-,
IL-17- or TNF-expressing CD4+ or CD8+ T cells in the MLNs and spleens was similar in
WT and Aim2–/– mice (Figure 4-2G). In addition, the prevalence of splenic and MLNassociated CD11b+ cells producing TNF or IL-6 was also similar in WT and Aim2–/– mice
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Figure 4-2. AIM2 governs colorectal tumorigenic susceptibility independently of
inflammasomes and a number of inflammatory mediators.
(A) Caspase-1 processing in colon lysates from WT and Aim2–/– mice 14 days after
injection of AOM. (B) Levels of IL-18 in the colon tissues and sera. (C) Levels of IL-1b
in colon tissues. (D) The lengths of colon from WT and Aim2–/– mice 14 days after
injection of AOM. (E) Immunoblot analysis (left) and densitometric quantification of
band intensity of phosphorylated and total ERK and IκBa (right) in colon tissues of WT
and Aim2–/– mice 14 days after injection of AOM. (F) Levels of IL-6, TNF, G-CSF, and
KC in colon tissues. (G) Percentages of CD4+ cells, CD4+ cells expressing IFN-γ or IL17, CD8+ cells, CD8+ cells expressing IFN-γ, CD11b+ cells, and CD11b+ cells expressing
IL-6 or TNF. *p < 0.05; **p < 0.01; NS, not statistically significant (two-tailed t test [B–
D, F, and G]). Data are from one experiment representative of two independent
experiment (A–C and G) or pooled from three independent experiments (D–F; mean and
SEM in B–G).
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Figure 4-3. AIM2 governs colorectal tumorigenic susceptibility independently of
the magnitude of inflammation.
(A) Relative expression of genes encoding IL-22 and IL-23p19 in colon tissues of
untreated WT and Aim2–/– mice or in WT and Aim2–/– mice 14 days after injection of
AOM. (B) Relative expression of genes encoding IFN-β, IFN-γ and IL-17A in colon
tissues of untreated WT and Aim2–/– mice or in WT and Aim2–/– mice 14 days after
injection of AOM. (C) Relative expression of genes encoding TGFβ1, TGFβ2 and IL-10
in colon tissues of untreated WT and Aim2–/– mice or in WT and Aim2–/– mice 14 days
after injection of AOM. (D) Automated hematology analyzer of white blood cell (WBC)
populations in the whole blood of untreated WT and Aim2–/– mice and WT and Aim2–/–
mice 14 or 80 days after injection of AOM. *p < 0.05; NS, not statistically significant;
two tailed t test. Data are from one experiment (D) or pooled from two independent
experiments (A–C, mean and SEM in A–D).
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(Figure 4-2G). The prevalence of total CD11b+ cells was, however, elevated in the
spleen, but not in the MLN. The modest increases in some inflammatory parameters in
mice lacking AIM2 suggested a role for an immunological component in shaping tumor
development in these mice. Identification of a role for AIM2 independently of classical
inflammasome signaling and a number of other inflammatory mediators also suggested,
at least in parts, alternative functions for AIM2 in the regulation of gastrointestinal
homeostasis during colorectal tumorigenesis.
AIM2 Controls Proliferation of Enterocytes
Given that the increased susceptibility to tumor development in Aim2–/– mice
could not be explained by differences in inflammasome activity or by a number of
inflammatory mediators, we asked whether AIM2 regulated cellular proliferation or death
following exposure to AOM and DSS. We used immunohistochemistry techniques to
identify proliferative cells in the colon of WT and Aim2–/– mice. We observed a
significantly higher number of BrdU+ proliferative cells per crypt in the colon of Aim2–/–
mice 14, but not 8, days after injection of AOM (Figure 4-4A). We confirmed these
findings and found a significantly higher number of Ki67+ cells per crypt in the intestinal
epithelium of Aim2–/– mice 14 days after injection of AOM compared with WT mice,
whereas no difference was observed in untreated WT and Aim2–/– mice (Figure 4-4A).
Further, we used microarray analysis to screen for genes expressed differentially in colon
tissues of WT and Aim2–/– mice 14 days after injection of AOM. Using this approach, we
indeed identified increased expression of genes encoding molecules involved in cell
proliferation in Aim2–/– mice relative to their expression in WT mice (Figure 4-4B).
These included genes encoding S100A9 and BIRC5, which have previously been linked
to colorectal carcinoma in humans [126-128]. We confirmed using qRT-PCR analysis an
increased expression of the top three differentially expressed genes encoding molecules
involved in proliferation, S100A9, SNRPD1 and DBF4, identified in our microarray
(Figure 4-4C).
To further investigate the mechanism of unchecked cellular proliferation when
AIM2 was absent, we examined activities of the phosphatidylinositol 3-Kinase–AKT
pathway, which has a major role in cell proliferation and survival and in development of
cancer [129]. We found increased phosphorylation of AKT at Ser473 in Aim2–/– mice
compared with WT mice 14 days after injection of AOM (Figure 4-4D), indicating
activation of the AKT pathway. Phosphorylation of AKT at Ser473 was similar between
WT and Aim2–/– mice 80 days after injection of AOM (Figure 4-4D). The
phosphatidylinositol 3-Kinase-AKT pathway is negatively regulated by the tumor
suppressor PTEN [130]. Phosphorylation of PTEN at S380, T382, and T383 maintains
PTEN in a relatively inactive state [131]. Indeed, we saw increased phosphorylation of
PTEN at S380, T382, and T383 in Aim2–/– mice compared with WT mice 14 days after
injection of AOM (Figure 4-4D). Increased AKT activation and transcription of genes
involved in cell proliferation could explain increased proliferation in the colon of mice
lacking AIM2 following damage induced by AOM. Consistent with increased AKT
activation, we found an elevated level of the transcription factor and proto-oncogene c-
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Figure 4-4. AIM2 suppresses overt proliferation.
(A) Quantification of the number of BrdU+ cells in each crypt of WT (day 8, n = 3; day
14, n = 5) and Aim2–/– (day 8, n = 4; day 14, n = 5) mice. Quantification of the number of
Ki67+ in each crypt of WT (day 0, n = 4; day 14, n = 4) and Aim2–/– (day 0, n = 3; day 14,
n = 4) mice. (B) Microarray analysis of genes encoding molecules involved in
proliferation with significantly higher or lower expression in Aim2–/– mice 14 days after
injection of AOM compared with their WT counterparts. (C) Real-time qRT-PCR
analysis of genes encoding S100A9, SNRPD1, and DBF4 in WT and Aim2–/– mice 14
days after injection of AOM. (D and E) Immunoblot analysis of phosphorylated and total
AKT and phosphorylated and total PTEN (D) or c-Myc, HIF1-a and GAPDH (loading
control; E) from colon tissues. (F) Real-time qRT-PCR analysis of the gene encoding cMyc in colon tissues of mice 14 days after injection of AOM. (G and H) Immunoblot
analysis of caspase-3 (G) and -7 activation (H) in colon tissues of mice 8 days after
injection of AOM. At least 20 crypts were counted in each animal (A). *p < 0.05; **p <
0.01; ***p < 0.001; ****p < 0.0001; NS, no statistical significance (two-tailed t test [A,
C, and F]). Data represent one experiment with two biological replicates per genotype (B)
or from one experiment representative of two independent experiments (A, C, and D–H)
(mean and SEM in A, C, and F).

32

Myc in Aim2–/– mice compared with WT mice 14 and 80 days after injection of AOM
(Figure 4-4E). Expression of the transcription factor HIF1-α, however, was similar
between WT and Aim2–/– mice (Figure 4-4E). We further confirmed by qRT-PCR
analysis an increased expression of the gene encoding c-Myc (Figure 4-4F). In addition,
increased intestinal cell proliferation was linked to reduced apoptosis because the levels
of caspase-3 and caspase-7 activation in the colon of Aim2–/– mice decreased compared
with that in WT mice (Figure 4-4G–H). To examine possible intrinsic defects in the
mucus layer in mice lacking AIM2, we analyzed the thickness of the mucus layer and the
expression of genes encoding mucin, MUC2, MUC3 and MUC4, in WT and Aim2–/–
mice. We found that the thickness of the mucus layer lining the large intestine and the
expression levels of genes encoding MUC2, MUC3 and MUC4 were similar in WT and
Aim2–/– mice (Figure 4-5A–B). In addition, we quantified the number of goblet cells and
observed similar numbers of these cells in the crypts of WT and Aim2–/– mice
(Figure 4-5C).
AIM2 Controls Expansion of Intestinal Stem Cells
We and others have previously identified that intestinal stem cells as the “cell-oforigin” of intestinal cancer [77, 132]. We hypothesized that the dramatic increase in cell
proliferation and tumor formation in Aim2–/– mice was caused by a population of
intestinal stem cells which is susceptible to oncogenic insults. To investigate this, we
cultivated and measured the growth rate of stem cells harvested from the colonic epithelia
of untreated WT and Aim2–/– mice. Remarkably, colonic epithelial stem cells harvested
from Aim2–/– mice consistently formed more organoids over five days compared with
those harvested from WT mice (Figure 4-6). In addition, we measured the diameters of
these organoids and found a greater proportion of organoids originated from Aim2–/– mice
with a larger size compared with those isolated from WT mice (Figure 4-6). These data
indicated that stem cells derived from the colon of Aim2–/– mice exhibited an increased
capacity to proliferate.
We and others have previously demonstrated that stem cells or progenitor cells in
the small intestine of mice are highly susceptible to tumorigenesis induced by aberrant
activating β-catenin mutations [77, 133]. These cells are marked by Prom1 (CD133), a
marker of cancer stem cells in human intestinal tumors that arise as a result of aberrant
Wnt signaling [134, 135]. To investigate the role of AIM2 in this pathway, we used the
Prom1CreERT2-LacZ (C-L)/+; Ctnnb1lox(ex3)/+; RosaZsGreen mouse strain to investigate
proliferation of Prom1+ cells following aberrant Wnt signaling [77]. The Prom1C-L/+
mouse strain contains an inducible Cre and a nuclear LacZ reporter allele knocked into
the Prom1 locus, which allowed us to detect cells expressing Prom1 using βgalactosidase staining. This mouse strain also encodes a Cre-dependent RosaZsGreen
reporter allele for use in lineage tracing, which is expressed irreversibly in Prom1+ cells
when CreERT2 is induced from the Prom1C-L/+ locus following tamoxifen treatment.
Further, the Wnt signaling pathway is aberrant in this mouse strain owing to the presence
of a Cre-dependent mutant allele of β-catenin (Ctnnb1lox(ex3)). To determine whether
colon cells from mice lacking AIM2 exhibited increased tumor susceptibility to Wnt
signaling, we crossed Aim2–/– mice to Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsGreen mice.
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Figure 4-5. Intact mucus layer in WT and Aim2–/– mice.
(A) Area of the mucus layer was measured from 5–7 different sections of the same mouse
using ImageJ (n = 3 mice). (B) Relative expression of genes encoding MUC2, MUC3,
and MUC4 in untreated WT and Aim2–/– mice or in WT and Aim2–/– mice 14 days after
injection of AOM. (C) The number of goblet cells was quantified in each crypt (50 crypts
per mouse) in the colon of WT and Aim2/ mice stained with PAS and Alcian blue. Two
tailed t test (A–C). NS, not statistically significant. Data represent one experiment (mean
and SEM).
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Figure 4-6. AIM2 controls proliferation of intestinal progenitor stem cells.
Formation of organoids derived from colonic stem cells harvested from untreated WT
and Aim2–/– mice. Quantification of the number (top right) and size of organoids (bottom
right). Scale bars, 50 mm (left) or 200 mm (right). Data represent one of three
independent experiments.
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We used β-galactosidase staining to detect nuclear LacZ expression from the Prom1
promoter. We found that a loss of AIM2 did not alter Prom1 expression pattern in the
large intestine and the majority of cells in the colonic crypts expressed Prom1
(Figure 4-7A). Remarkably, three weeks after induction of aberrant β-catenin activation
by tamoxifen treatment, we observed a significant increase in the stem cell activity of
Prom1+ cells, indicated by GFP lineage tracing using the RosaZsG allele, in the colon of
Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsG; Aim2–/– mice compared with Prom1C-L/+;
Ctnnb1lox(ex3)/+; RosaZsG; Aim2+/+ mice (Figure 4-8A). There was a significantly
increased number of GFP+ cells in Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsG; Aim2–/– mice
relative to Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsG; Aim2+/+ mice (Figure 4-7B). GFP+ cells
populated almost the entire crypts in Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsG; Aim2–/– mice
(Figure 4-8A). We observed very few crypts that were comprised of GFP+ cells in
Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsG; Aim2+/+ mice (Figure 4-8A), indicating that a
small population of Prom1+ cells could still potentially behave as stem or progenitor cells
in the colon of Aim2+/+ mice. These findings suggested that the lack of AIM2 increased
the stem cell activity of Prom1+ cells following aberrant Wnt activation.
Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsG mice succumb within six weeks of
tamoxifen induction owing to extensive tumor formation initiated from Prom1+ stem cells
in the small intestine (Figure 4-8B). Although we did not observe macroscopic tumors in
the large intestine of these animals, we found an elevated number of Ki67+ cells,
increased staining for phosphorylated AKT, total AKT and c-Myc and a small number of
abnormal crypts in the large intestine of Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsG; Aim2–/–
mice compared with Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsG; Aim2+/+ mice
(Figure 4-7C and Figure 4-8A). We also noticed accelerated tumorigenesis, increased
staining for phosphorylated AKT and c-Myc in the small intestine of Prom1C-L/+;
Ctnnb1lox(ex3)/+; RosaZsG; Aim2–/– mice compared with Prom1C-L/+; Ctnnb1lox(ex3)/+;
RosaZsG; Aim2+/+ mice (Figure 4-8B). These results validated the colitis-associated
colorectal cancer model and suggested that AIM2 played a role in protecting tumor
formation in the intestine. Overall, loss of AIM2 resulted in an increased stem cell
activity in the colon following aberrant Wnt-signaling in the intestinal stem-cell niche.
To further confirm a role for the epithelial compartment in AIM2-mediated
protection against colon cancer development, we performed bone marrow transplantation
experiments to examine the contribution of the radioresistant stromal compartment
relative to that of the hematopoietic compartment in governing colon tumorigenesis. As
expected, Aim2–/– mice that received Aim2–/– bone marrow were more susceptible to
tumorigenesis compared to WT mice that received WT bone marrow (Figure 4-9A).
After 80 days post-AOM injection, Aim2–/– mice that received WT bone marrow had
significantly increased tumor burden compared to WT mice that received WT bone
marrow (Figure 4-9B–C). These results provided evidence to suggest that AIM2 in the
stromal compartment could play a role in the protection against colorectal tumorigenesis.
WT mice that received Aim2–/– bone marrow also showed slightly increased tumor
burden compared with WT mice that received WT bone marrow, suggesting that the bone
marrow compartment contributed to colorectal tumorigenesis via a yet-undefined
mechanism.
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Figure 4-7. Loss of AIM2 increased proliferation initiated by Prom1+ cells in the
large intestine following -catenin activation.
(A) b-galactosidase staining of Prom1-expressing cells indicating similar expression
pattern in the large intestine of Prom1C-L/+; Aim2+/+ and Prom1C-L/+; Aim2–/– mice. Scale
bar, 20 mm. (B) Quantification of the number of GFP+ cells per field in the large intestine
of Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsG; Aim2+/+ and Prom1C-L/+; Ctnnb1lox(ex3)/+;
RosaZsG; Aim2–/– mice 3 weeks post-tamoxifen (TMX) induction. Fields from 10 images
for each genotype were quantified. (C) H&E (left) and Ki67 (right) staining of the large
intestine of Prom1C-L/+; Ctnnb1lox(ex3)/+; RosaZsG; Aim2+/+ and Prom1C-L/+; Ctnnb1lox(ex3)/+;
RosaZsG; Aim2–/– mice 6 weeks post-TMX induction. Arrowheads indicate abnormal
crypts. Scale bar, 50 mm (H&E, top), 100 mm (H&E, bottom), 200 mm (Ki67). Mean
and SEM in (B). ****p < 0.0001 (two-tailed t test [B]).
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Figure 4-8. AIM2 controls expansion of intestinal stem cells.
(A) Lineage tracing (left) of Prom1+ cells (green) in the large intestine 3 weeks posttamoxifen (TMX) induction. Blue staining indicates DAPI. Scale bar, 100 mm. Staining
for phosphorylated AKT (p-AKT, Ser473), total AKT and c-Myc (right) in the large
intestine 6 weeks post-TMX induction. Scale bar, 200 mm. Arrow heads indicate early
lesions with intense staining for the respective markers. (B) H&E staining and staining
for p-AKT (Ser473), total AKT, c-Myc, and Ki67 staining in the small intestine 6 weeks
post-TMX induction. Scale bars, 250 mm(H&E) and 100 mm (p-AKT, total AKT, cMyc, and Ki67 staining).

38

Figure 4-9. The role of hematopoietic and non-hematopoietic compartments in
AIM2-mediated protection of colorectal tumorigenesis.
(A) Four groups of mice were generated by bone marrow transplantation: (1) WT → WT,
n = 9; (2) Aim2–/– → WT, n = 9; (3) WT → Aim2–/–, n = 7; (4) Aim2–/– → Aim2–/–, n = 8. 6
weeks following bone marrow transplantation, mice were treated with AOM followed by
DSS, and colon tumors were counted 80 days after injection of AOM. The numbers of
tumors in the colon and percentages of tumors of less than 2 mm or 2–4 mm in diameter
were quantified. (B) Representative images of colon tumors. (C) Representative H&E
images of colon tumors. Magnification: 20. Data represent one experiment (mean and
SEM). *p < 0.05; **p < 0.01; ***p < 0.001. One-way ANOVA (A).
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AIM2 Protects Colorectal Tumorigenesis by Modulating the Gut Microbiota
Intestinal cell proliferation and the development and progression of colorectal
cancer is regulated by the composition of gut microbiota. Studies have reported that the
NOD-like receptor protein NLRP6 modulates the microbial ecology and protects against
colon tumor development [136, 137]. To assess whether the gut microbiota plays a role in
the increased tumorigenic susceptibility of Aim2–/– mice, we performed 16S rRNA gene
sequencing analysis of the gut microbiota derived from stool samples of separately
housed WT and Aim2–/– mice. Our 16S rRNA gene sequencing analyses revealed a
markedly distinct intestinal microbial landscape in separately housed WT and Aim2–/–
mice (Figure 4-10A–B). Relative to WT mice, Aim2–/– mice harbored increased levels of
Akkermansia muciniphila, Anaeroplasma, and decreased levels of Anaerostipes,
Bifidobacterium, Flexispira, Prevotella and Paraprevotella species (Figure 4-10A). Of
these, previous reports have linked an increase in Akkermansia and a decrease in
Prevotellaceae with the development of colonic tumorigenesis [138]. Interestingly, cohousing equilibrated the relative abundance of Anaerostipes, Flexispira, Prevotella, and
Paraprevotella in WT and Aim2–/– mice (Figure 4-10A–B).
We took advantage of the transmissible nature of the gut microbiota to investigate
whether susceptibility to colorectal tumorigenesis could be reduced in Aim2–/– mice by
co-housing them with WT mice. We found a striking reduction in the number and
incidence of colon tumors in co-housed Aim2–/– mice compared with separately housed
Aim2–/– mice (Figure 4-10C–D). Intriguingly, WT mice co-housed with Aim2–/– mice
responded conversely and developed more tumors compared with their separately housed
controls (Figure 4-10C–D). Co-housed Aim2–/– mice were still more susceptible to
tumorigenesis compared with co-housed WT mice (Figure 4-10C–D), supporting the
concept that both genetic and environmental factors contributed to the development of
cancer.
Discussion
Members of the pattern-recognition receptor family are central players in the
regulation of infectious, inflammatory and metabolic diseases. Our laboratory and others
have previously shown that the innate immune receptors NLRP3, NLRP6, NLRP12,
NLRC4, STING and NOD2 are required for the protection against colitis and colitisassociated tumorigenesis [27-31, 139-143]. However, the role of AIM2-like receptors,
including AIM2 and IFI16 or p202, in regulating gastrointestinal health and disease is
unknown.
The innate immune receptor AIM2 was originally isolated from human melanoma
cells [37]. AIM2 directly binds dsDNA and initiates the recruitment of ASC and caspase1 to assemble a multi-protein inflammasome complex. Whether AIM2 can operate
independently of inflammasomes in the cell is unclear. Here, we identified an unexpected
function for AIM2 that departs from its known role in inflammasome signaling. Certain
members of the NLR family, including NLRP6 and NLRP12, have also been shown to
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Figure 4-10. Reciprocal exchange of gut microbiota reduces susceptibility of Aim2–
/– mice to colon cancer.
(A) Bacterial species from feces that had the greatest difference in abundance between
single housed WT and Aim2–/– mice and their relative abundance in co-housed WT and
Aim2–/– mice, based on analysis of the 16S rRNA gene, are shown in a heatmap in
alphabetical order. (B) Principal component analysis of (A). (C) The total number of
tumors observed in the colon of separately housed and co-housed mice 80 days after
injection of AOM. (D) Representative images of colons in (C). Data represent one
experiment (A and B) or pooled from two independent experiments (C and D) (mean and
SEM in [C]). *p < 0.05; ****p < 0.0001. One-way ANOVA (C).
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exert inflammasome-dependent and inflammasome-independent functions in health and
disease [144].
The mechanism driving AIM2-dependent protection against tumorigenesis is the
ability of AIM2 to tightly suppress overt cellular proliferation of intestinal epithelial
cells. Whether AIM2 directly interacts and prevents phosphorylation of the kinase AKT
is unclear. Unlike the role for NLRP6 in targeting goblet cell mucin secretion [145],
AIM2 specifically controlled expansion and proliferation of intestinal stem cells. The
larger population of cells derived from Prom1+ cells lining the intestinal crypt in mice
lacking AIM2 following aberrant induction of β-catenin indicated that these cells might
be highly proliferative and less well-differentiated. In vitro studies have shown that
ectopic expression of AIM2 can be used to promote cell cycle arrest and inhibition of cell
proliferation [146]. These findings, together, highlight the dynamic roles of AIM2 in
regulating cell functions during cell growth and tumorigenesis.
In mice exposed to AOM-DSS, the expression of AIM2 was down-regulated as
early as 14 days, suggesting that robust AIM2 expression was critical for preventing early
tumorigenic events. The levels of AIM2 expression in tumor tissues of patients have been
shown to greatly influence the outcome of the disease. Patients who have tumor cells that
completely lacked AIM2 expression have a more than 3-fold higher mortality rate than
patients whose tumor cells retained some AIM2 expression [26]. The precise molecular
signal that triggers down-regulation of AIM2 expression during colorectal tumorigenesis
is unknown and therapeutic strategies aimed at increasing colonic AIM2 expression may
help to prevent overt tumorigenesis in susceptible individuals.
Of particular clinical relevance is the observation that defective AIM2 function
leading to tumorigenesis can be partially prevented by a transmissible gut microbiota in
cohoused mice. This finding indicates that engraftment of healthy donor gut microbiota
to patients suffering chronic intestinal inflammation could reduce the risk of developing
colorectal cancer. The microbiota plays a central role in modulating cell proliferation in
the intestine. Gut–associated Lactobacillus murinus enhances cell proliferation in the
mouse intestine [147]. Furthermore, gut microbiota has the capacity to induce IL-17C
production in intestinal epithelial cells via a MyD88-dependent pathway, which leads to
increased expression of the prosurvival proteins Bcl2 and Bcl-xL to drive colorectal
tumorigenesis [148]. Carbohydrate-derived metabolites generate by gut microbiota has
also been shown to enhance colon epithelial cell proliferation in an ApcMin/+ mouse model
lacking the gene encoding the DNA mismatch repair protein MutS homolog 2 (MSH2)
[149].
During barrier damage, it is possible that DNA from microbial species that have
invaded intestinal cells or DNA from dying host cells could be sensed by AIM2 in
intestinal cells. It is tempting to hypothesize that instead of contributing to the
inflammatory response further by inducing activation of the inflammasome, AIM2
responds by dampening cellular proliferation in the intestine. How AIM2 might be
sensing different environmental cues in the cytoplasm to direct context-specific cellular
processes is an exciting question for future investigation. In conclusion, our findings
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demonstrated a requirement for AIM2 in the protection against colorectal cancer.
Therapeutic modulation of AIM2 expression and gut microbiota could play a central role
in reducing the risk of developing colorectal cancer.
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CHAPTER 5. DETRIMENTAL TYPE I INTERFERON SIGNALING
DOMINATES PROTECTIVE AIM2 INFLAMMASOME RESPONSES DURING
FRANCISELLA NOVICIDA INFECTION
Introduction
Innate immune sensors mediate the recognition of PAMPs and DAMPs and are
central regulators of host defense against microbial infections. Upon activation, immune
sensors induce the production of inflammatory cytokines and interferons. Certain innate
immune cytoplasmic sensors have a unique ability to form a caspase-1-activating multiprotein complex termed the inflammasome. These sensors include members of the
nucleotidebinding oligomerization domain (NOD), leucine-rich repeat (LRR)-containing
protein family members, AIM2 and pyrin [150]. Of these, AIM2 binds directly to dsDNA
and assembles the inflammasome to mediate the release of interleukin IL-1β and IL-18
and the induction of pyroptosis. AIM2 orchestrates protective inflammasome-dependent
responses against microbial infection in vivo, including infection by the Gram-negative
bacterial pathogen F. novicida [150].
Components of the type I IFN signaling pathway are essential for the activation of
AIM2 inflammasome during infection by F. novicida and L. monocytogenes [41-45, 151,
152]. During F. novicida infection, the DNA sensor, cGAS, and its adaptor, STING,
mediate the production of type I IFNs, which in turn drive expression of effector proteins
of cell-autonomous immunity leading to bacteriolysis and release of bacterial DNA for
recognition by AIM2 [150].
Type I IFN signaling during bacterial infection in vivo can be beneficial or
detrimental depending on the pathogen [153]. Whereas type I IFN signaling is protective
in mice infected with Streptococcus pneumoniae, or Streptococcus pyogenes, it is
detrimental in case of F. novicida or L. monocytogenes [50]. The requirement for type I
IFN signaling to activate the AIM2 inflammasome in macrophages is counterintuitive to
the observation that, type I IFN signaling is detrimental during in vivo infection with F.
novicida while the AIM2 inflammasome is protective. How the interplay between the
opposing effects of these signaling pathways determines the final outcome during F.
novicida infection has remained unclear. Here, we showed that the detrimental effects of
type I IFN signaling overrides protective AIM2 inflammasome responses.



Adapted with open access permission. Zhu, Q., Man S.M., Karki R., Malireddi R.K.,
Kanneganti, T.D. (2018). Detrimental type I Interferon signaling dominates protective
AIM2 Inflammasome responses during Francisella novicida Infection. Cell Reports. 22,
3168-3174.
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Results and Discussion
IFNAR Signaling Enhances Susceptibility to Infection by F. novicida
A recent study has demonstrated non-redundant functions for type I IFN receptor
subunits IFNAR1 and IFNAR2 independently of one another [154]. To directly compare
the effects of IFNAR1 and IFNAR2 during F. novicida infection, we infected WT mice
and mice lacking IFNAR1 (Ifnar1–/–) or IFNAR2 (Ifnar2–/–) with F. novicida and
monitored their survival. Whereas 65% of the infected WT mice died within 14 days,
only 13% of the Ifnar1–/– mice and 11% of the Ifnar2–/– mice succumbed to infection
(Figure 5-1A), suggesting that signaling by both IFNAR1 and IFNAR2 contribute to
increased susceptibility to infection by F. novicida. The resistance to F. novicida
infection in Ifnar1–/– mice is consistent with the observations of a previous study [155].
Furthermore, only 8% of mice lacking the transcription factor IRF9 (Irf9–/–), a component
of ISGF3 transducing type I IFN signaling, succumbed to infection by F. novicida over
14 days, essentially phenocopying Ifnar1–/– and Ifnar2–/– mice (Figure 5-1A). IRFs are
central components regulating type I IFN production in response to diverse pathogens.
Indeed, we found that Irf7–/– and Irf3–/–Irf7–/– mice were resistant to the infection
(Figure 5-1B). However, mice lacking IRF5, an IRF not critical for IFN production,
(Irf5–/–) were as susceptible as WT mice (Figure 5-1B). We also observed increased
resistance in Stinggt/gt mice (Figure 5-1B). Consistent with these results, we found
significantly lower bacterial burdens in the liver and spleen of Stinggt/gt mice, Irf7–/– mice,
and Irf9–/– mice 3 days after infection compared with WT mice (Figure 5-1C). Together,
these results suggest that the effector responses mediated by type I IFN signaling enhance
susceptibility to F. novicida infection in vivo.
The Detrimental Effects of Type I IFN Signaling Dominate the Protective Effects of
AIM2 during F. novicida Infection in vivo
To directly assess the relative contribution of IFNs and AIM2 in host defense
during F. novicida infection, we compared mice lacking components of the type I IFN
signaling pathway, such as IFNAR2, with mice lacking AIM2. Whereas Ifnar2–/– mice
were resistant to infection by F. novicida, with only 19% of the mice dying, all Aim2–/–
mice succumbed to infection within 6 days (Figure 5-2A). The disparate roles of type I
IFN signaling and AIM2 during F. novicida infection in vivo suggest a more complex
functional relationship between these two pathways.
To formally investigate the cumulative effects of type I IFN signaling and AIM2
during F. novicida infection, we bred Ifnar2–/– mice and Aim2–/– mice to generate mice
lacking both IFNAR2 and AIM2 (Ifnar2–/–Aim2–/–). Ifnar2–/–Aim2–/– mice had similar
numbers of neutrophils, macrophages, dendritic cells, CD8+ T cells and B cells in the
spleen, T cells in the thymus, and neutrophils, monocytes and B cells in the bone marrow
compared with WT mice (Figure 5-3A–C). We infected Ifnar2–/–Aim2–/– mice with F.
novicida and monitored their survival. Interesting, Ifnar2–/–Aim2–/– mice were resistant to
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Figure 5-1. Mice lacking IFNAR1 or IFNAR2 are resistant to F. novicida.
(A) Survival of WT, Ifnar1–/–, Ifnar2–/–, and Irf9–/– mice infected with F. novicida. (B)
Survival of WT, Irf7–/–, Irf3–/–Irf7–/–, Irf5–/– and Stinggt/gt mice infected with F. novicida.
(C) Bacterial burdens in the liver and spleen of WT, Stinggt/gt, Irf7/, and Irf9–/– mice 3
days after infection with F. novicida. NS, not significant; **p < 0.01, ***p < 0.001,
****p < 0.0001; log-rank test (A and B) or one-way ANOVA with Dunnett’s multiplecomparisons test (C). Data are pooled from three (C) or four (A and B) independent
experiments (mean and SEM in C).

46

Figure 5-2. Detrimental role of type I IFN signaling is dominant over AIM2
inflammasome responses during F. novicida infection.
(A) Survival of WT, Ifnar2–/–, Aim2–/–, and Ifnar2–/–Aim2–/– mice infected with F.
novicida. (B) Bacterial burdens in the liver and spleen of WT, Ifnar2–/–, Aim2–/–, and
Ifnar2–/–Aim2–/– mice 3 days after F. novicida infection. (C) Concentration of IL-18 in the
sera of WT, Ifnar2–/–, Aim2–/–, and Ifnar2–/–Aim2–/– mice 1 day after infection. (D)
Immunoblot analysis of pro-caspase-1 (Pro-Casp-1) and the caspase-1 subunit p20 (Casp1p20) in unprimed WT or mutant BMDMs left uninfected or untreated (Med, medium
alone) or assessed 20 hours after infection with F. novicida (MOI, 100; top), 5 hours after
transfection with poly(dA:dT) (middle), or 10 hours after infection with MCMV
(bottom). (E) Release of IL-1b (top) or IL-18 (middle) and death (bottom) of unprimed
BMDMs after treatment, as in (D). NS, not significant; *p < 0.05; **p < 0.01, ***p <
0.001, ****p < 0.0001; long-rank test (A) or one-way ANOVA with Dunnett’s multiple
comparisons test (B, C, and E). Data are pooled from three (B) or four (A and C)
independent experiments or are from one experiment representative of two independent
experiments (D and E) (mean and SEM in B, C, and E).
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Figure 5-3. Characterization of Ifnar2−/−Aim2−/− mice.
(A) Total number of neutrophils, macrophages, DCs, CD4+ T cells, CD8+ T cells, and B
cells in the spleen of WT mice and Ifnar2−/−Aim2−/− mice. (B) Total number of CD4+ T
cells and CD8+ T cells in the thymus of WT mice and Ifnar2−/−Aim2−/− mice. (C) Total
number of neutrophils, monocytes, and B cells in the bone marrow of WT mice and
Ifnar2−/−Aim2−/− mice. NS, not statically significant; *P<0.05 (two-tailed t test [A–C]).
Data are pooled from two independent experiments (A–C; mean and SEM in A–C).
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the infection similar to Ifnar2–/– mice, with only 19% of the mice dying of infection over
12 days compared with 100% in Aim2–/– mice (Figure 5-2A). Consistent with the
reduction in mortality, both Ifnar2–/–Aim2–/– and Ifnar2–/– mice had significantly lower
bacterial burdens in the liver and spleen 3 days after infection compared with WT mice,
while Aim2–/– mice were more susceptible to infection and had more bacterial burden
(Figure 5-2B). These results demonstrate that type I IFN signaling is dominant over
AIM2 inflammasome during F. novicida infection in vivo. Since both IFNAR1 and
IFNAR2 are required for mediating detrimental type I IFN signaling, it is likely that
Ifnar1–/–Aim2–/– mice are also resistant to the infection phenocopying Ifnar2–/–Aim2–/–
mice. Increased number of splenic CD4+ T cells in naïve Ifnar2–/–Aim2–/– mice is unlikely
to contribute to the susceptibility (Figure 5-3A), as bacterial burden in Ifnar2–/–Aim2–/–
mice was significantly lower than WT mice 3 days after infection when T cell responses
barely occurred.
We next investigated whether type I IFN signaling was required for AIM2
inflammasome-induced IL-18 production in vivo during F. novicida infection. Reduced
levels of IL-18 were observed in the sera of Aim2–/– and Ifnar2–/–Aim2–/– mice confirming
AIM2-dependent IL-18 production in the infected mice (Figure 5-2C). Notably, Ifnar2–/–
mice retained the ability to produce IL-18 after the infection indicating inflammasome
activation independently of type I IFNs in vivo (Figure 5-2C). The comparable level of
resistance to F. novicida infection in Ifnar2–/– mice and Ifnar2–/–Aim2–/– mice suggest that
the dominance of IFNAR signaling-mediated responses over AIM2 is independent of IL18.
As demonstrated previously [44], Ifnar2–/– BMDMs had an impaired ability to
activate caspase-1, trigger release of IL-1β and IL-18, and induce cell death in response
to F. novicida compared to the WT BMDMs (Figure 5-2D–E). Aim2–/– or Ifnar2–/–Aim2–
/–
BMDMs infected with F. novicida also failed to activate inflammasome responses,
confirming specificity of F. novicida infection to the AIM2 inflammasome
(Figure 5-2D–E). Inflammasome responses occurred normally in Ifnar2–/– cells after
poly(dA:dT) transfection or MCMV infection (Figure 5-2D–E). Consistent with previous
reports [44, 47], transfection of poly(dA:dT) did not induce IL-1β release in WT BMDMs
(Figure 5-2E), possibly due to an inability of poly(dA:dT) transfection in mediating IL1β expression. Collectively, these results demonstrate that unlike in macrophages, AIM2
inflammasome activation in vivo is retained even in the absence of type I IFN signaling.
Inflammatory Cytokine Production Is Intact in the Absence of Type I IFN Signaling
Previous studies showed that type I IFNs suppress production of proinflammatory cytokines to prevent inflammation-associated damage and lethality during
S. pneumonia infection [156]. To identify whether the levels of pro-inflammatory
cytokines are differentially regulated by type I IFN signaling during infection by F.
novicida, we analyzed a range of cytokines and chemokines 1 day after F. novicida
infection, when WT, Ifnar2–/–, and Ifnar2–/–Aim2–/– mice had similar bacterial burden
(Figure 5-4A). Levels of the pro-inflammatory cytokines GM-CSF, TNF, IL-6, MIP1-α,
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IL-17, IL-12 and IFNγ and the anti-inflammatory cytokine IL-10 in the liver were
comparable between WT, Ifnar2–/–, and Ifnar2–/–Aim2–/– mice (Figure 5-4B). The levels
of these proinflammatory cytokines were also similar in the sera of WT, Ifnar2–/–, and
Ifnar2–/–Aim2–/– mice at this time point (Figure 5-4C). We also measured levels of the
cytokines 2 days after infection, when bacterial burdens were similar between the animals
(Figure 5-5A). Whereas levels of TNF, IL-6, MIP1-α, IFNγ and IL-10 were similar in
the liver (Figure 5-5B), levels of GM-CSF and IL-12 were decreased in both Ifnar2–/–
and Ifnar2–/–Aim2–/– mice and level of IL-17 was decreased in Ifnar2–/– mice
(Figure 5-5B). Interestingly, we found similar levels of TNF, IL-6, MIP1-α and IL-10
but increased levels IL-17 and IL-12 in the sera of Ifnar2–/– and Ifnar2–/–Aim2–/– mice
compared with WT animals (Figure 5-5C), which is consistent with a previous study
[155], suggesting that circulating IL-17 and IL-12 may also contribute to host defense at
this time point. Level of IFNγ was reduced in Ifnar2–/–Aim2–/– but not Ifnar2–/– mice. This
could be due to a lack of IL-18-induced IFNγ production in Ifnar2–/–Aim2–/– mice
(Figure 5-5C).
Type I IFN Signaling Controls Activation of Apoptotic Caspases and Cell Death
Type I IFN signaling has been shown to exert its detrimental effects to the host
via induction of cell death during L. monocytogenes and Brucella abortus infection [50].
To determine whether type I IFN signaling promotes excessive cell death during F.
novicida infection, we measured levels of apoptotic caspase-8, -3, and -7 in liver tissues
of WT, Ifnar2–/–, and Ifnar2–/–Aim2–/– mice. In line with our hypothesis, the levels of
cleaved caspase-8, -3 and -7 were lower in Ifnar2–/– and Ifnar2–/–Aim2–/– mice than in WT
mice 1 and 2 days after infection (Figure 5-6A–B). These results suggest that induction
of apoptosis is impaired in the absence of type I IFN signaling. Levels of cleaved
caspase-3 and -7 were similar between WT and Aim2–/– mice (Figure 5-7A).
Additionally, Ifnar2–/– and Ifnar2–/–Aim2–/– mice showed decreased cleavage of caspase-8,
-3 and -7 on day 3 post infection (Figure 5-6C), whereas Aim2–/– mice had higher levels
of cleaved caspase-8, -3 and -7, possibly due to excessive liver damage caused by
uncontrolled bacteria replication (Figure 5-6C). TUNEL staining also indicated reduced
cell death in Ifnar2–/– and Ifnar2–/–Aim2–/– mice and enhanced cell death in Aim2–/– mice
after the infection (Figure 5-7B). We further tested role of AIM2 in mediating apoptosis
in vitro during F. novicida infection by measuring cleavage of apoptotic caspases.
Cleavage of caspase-8 and -3 was increased in Aim2–/– BMDMs compared with WT cells
after the infection (Figure 5-7C). A previous study has shown that the AIM2
inflammasome negatively regulates type I IFNs production [157]. It is possible that
increased levels of type I IFNs in Aim2–/– BMDMs induces activation of caspase-8 and -3.
Interestingly, caspase-7 activation was decreased in Aim2–/– BMDMs (Figure 5-7C).
Caspsae-7 has been reported as a substrate of caspase-1 [158]. The reduced cleavage of
caspase-7 in Aim2–/– BMDMs could be due to impaired caspase-1 activation during the
infection. Overall, these results suggest that Aim2−/− BMDMs have increased apoptosis
after F. novicida infection. On the other hand, apoptosis occurred similarly in infected
Aim2–/– mice initially but further increased at a later stage of the infection compared with
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Figure 5-4. Type I IFN signaling does not alter production of a range of
inflammatory cytokines during F. novicida infection.
(A) Bacterial burdens in the liver and spleen of WT, Ifnar2–/–, and Ifnar2–/–Aim2–/– mice 1
day after infection with F. novicida. (B and C) Concentrations of GM-CSF, TNF, IL-6,
MIP1-α, IL-17, IL-12 (p70), IFNγ, and IL-10 in the liver (B) or serum (C) of WT, Ifnar2–
/–, and Ifnar2–/–Aim2–/– mice 1 day after infection, as in (A). NS, not significant; one-way
ANOVA with Dunnett’s multiple-comparisons test. Data are pooled from two (B and C)
or three (A) independent experiments (mean and SEM in A–C).
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Figure 5-5. Inflammatory cytokine production after F. novicida infection.
(A) Bacterial burdens in the liver and spleen of WT, Ifnar2−/−, and Ifnar2−/−Aim2−/− mice
2 days after infection with F. novicida. (B–C) Concentrations of GM-CSF, TNF, IL-6,
MIP1-α, IL-17, IL-12 (p70), IFNγ, and IL-10 in the liver (B) or serum (C) of WT,
Ifnar2−/−, and Ifnar2−/−Aim2−/− mice 2 days after infection as in (A). NS, not significant;
*P<0.05; **P<0.01, ***P<0.001, ****P<0.0001 (one-way ANOVA with Dunnett’s
multiple-comparisons test [A–C]). Data are pooled from two independent experiments
(A–C; mean and SEM in A–C).
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Figure 5-6. Type I IFN signaling induces apoptotic cell death.
(A–C) Immunoblot analysis of pro-caspase-8, cleaved caspase-8, pro-caspase-3, cleaved
caspase-3, pro-caspase-7, cleaved caspase-7, and GAPDH in liver tissue from uninfected
animals or WT, Ifnar2−/−, and Ifnar2−/−Aim2−/− mice 1 day (A) or 2 days (B) after F.
novicida infection or from WT, Ifnar2−/−, Ifnar2−/−Aim2−/−, and Aim2−/− mice 3 days (C)
after F. novicida infection. (D) Immunoblot analysis of TRAIL, DR5, and GAPDH in
liver tissues of uninfected animals or WT, Ifnar2−/−, and Ifnar2−/−Aim2−/− mice 1 day after
infection. The asterisk indicates a non-specific band. (E) Immunoblot analysis of procaspase-8, cleaved caspase-8, pro-caspase-3, cleaved caspase-3, pro-caspase-7, cleaved
caspase-7, and GAPDH in liver tissue from WT and Ifnar2/ mice treated with PBS or
rTRAIL 1 day after F. novicida infection. (F) Survival of WT mice that received TRAIL
neutralizing antibody or isotype control, Ifnar2−/− mice, and Ifnar2−/−Aim2−/− mice
infected with F. novicida. NS, not significant; **p < 0.01; ***p < 0.001, ****p < 0.0001;
long-rank test (F). Data are pooled from three independent experiments (F) or are from
one experiment representative of two (B and E) or four (A, C and D) independent
experiments.
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Figure 5-7. Analysis of apoptotic cell death and TRAIL pathway during F.
novicida infection.
(A) Immunoblot analysis of cleavage of caspase-8, -3 and -7 and GAPDH in liver tissue
from WT and Aim2−/− mice 1 day after F. novicida infection. (B) TUNEL staining of
liver tissues from WT, Ifnar2−/−, Ifnar2−/−Aim2−/−, and Aim2−/− mice 3 days after F.
novicida infection. Scale bar, 100 μm. (C) Immunoblot analysis of cleavage of caspase-8,
-3 and -7 and GAPDH in unprimed WT or mutant BMDMs left uninfected or assessed 20
hours after infection with F. novicida (MOI, 100). (D) Relative expression of genes
encoding TRAIL and DR5 in liver tissues of uninfected animals or WT, Ifnar2−/−, and
Ifnar2−/−Aim2−/− mice 1 day after infection. (E) Immunoblot analysis of TRAIL, DR5 and
GAPDH in liver tissue from uninfected animals or WT and Aim2−/− mice 1 day after F.
novicida infection. The asterisk indicates a non-specific band. (F) Bacterial burdens in the
liver and spleen of WT mice that received TRAIL-neutralizing antibody or isotype
control and Ifnar2−/−Aim2−/− mice 3 days after infection with F. novicida. (G)
Immunoblot analysis of cleavage of caspase-8, -3 and -7 and GAPDH in liver tissue of
WT mice that received TRAIL-neutralizing antibody or isotype control and
Ifnar2−/−Aim2−/− mice after F. novicida infection. NS, not significant; ****P<0.0001
(one-way ANOVA with Dunnett’s multiple-comparisons test [D and F]). Data are pooled
from two experiments (D) or from one experiment representative of two (A, C and E)
independent experiments or from one experiment (B, F and G; mean and SEM in D and
F).
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WT mice. This could be explained by the cell-type specific differences in AIM2 function
between BMDMs and liver where the majority of cells are hepatocytes. Similar to the
liver tissues, BMDMs from Ifnar2–/– and Ifnar2–/–Aim2–/– mice had reduced levels of
cleaved caspase-8, -3 and -7 compared with WT cells following F. novicida infection
(Figure 5-7C), indicating a potential role for type I IFN signaling in activating apoptotic
caspases in vitro. The defective caspase-1 activation in Ifnar2–/– and Ifnar2–/–Aim2–/–
BMDMs may lead to impaired caspase-7 cleavage in these cells.
TRAIL is upregulated by type I IFNs and was shown to mediate type I IFN
signaling-induced cell death during viral and bacterial infections [50]. TRAIL binds to its
receptor DR5 and triggers apoptosis by driving caspase-8-mediated caspase-3 and -7
activation. We therefore hypothesize that type I IFN signaling may promote cell death
through TRAIL pathway. We measured expression levels of TRAIL and DR5 in the liver
and found that expression of TRAIL was upregulated in the liver of WT mice 1 day after
infection; however, the induction was abrogated in Ifnar2–/– and Ifnar2–/–Aim2–/– mice
(Figure 5-6D, Figure 5-7D). DR5 was similarly induced between the animals
(Figure 5-6D, Figure 5-7D). Interestingly, the level of TRAIL was slightly reduced in
Aim2–/– mice after the infection, while the level of DR5 was similar (Figure 5-7E). IFNγ
can induce TRAIL expression in addition to type I IFNs (Park et al., 2004). Infected
Aim2–/– mice may exhibit reduced IFNγ production (Pierini et al., 2013) which in turn
leads to a modest reduction in TRAIL. However, the reduction was not significant
enough to reduce apoptosis in Aim2–/– mice, suggesting that other mechanisms such as
Fas (CD95/APO-1) signaling may co-exist to promote marginal cell death. Furthermore,
treatment of rTRAIL increased cleavage of caspase-8, -3 and -7 in Ifnar2–/– mice
compared with PBS-treated Ifnar2–/– mice after the infection (Figure 5-6E), indicating
that type I IFN signaling induces TRAIL-mediated apoptosis during F. novicida
infection. To further confirm that type I IFN signaling exacerbates F. novicida infection
via the TRAIL pathway, we treated WT mice with TRAIL-neutralizing antibody or
isotype control and infected and infected these mice along with Ifnar2–/– and Ifnar2–/–
Aim2–/– mice with F. novicida. A higher dose of F. novicida was used in these
experiments so that any protective effects rendered by TRAIL neutralization would be
more prominent. Although 90% of WT mice that received isotype control died, only 60%
of WT mice that received TRAIL-neutralizing antibody succumbed to infection over 14
days (Figure 5-6F). Neutralization of TRAIL also appeared to decrease bacterial burdens
in the liver and spleen 3 days post infection (Figure 5-7F), demonstrating a detrimental
role for TRAIL pathway during F. novicida infection in vivo. Moreover, WT mice that
received TRAIL-neutralizing antibody had reduced levels of cleaved caspase-8, -3 and -7
compared with the control animals after the infection (Figure 5-7G), further confirming
that TRAIL pathway leads to activation of apoptotic caspases during F. novicida
infection.
In this study, we demonstrate type I IFN-induced apoptosis in the liver following
F. novicida infection and the pathogenic effects of type I IFN signaling dominate the
protective AIM2 responses (Figure 5-8). Type I IFN signaling has been shown to
enhance susceptibility to L. monocytogenes and B. abortus infection by promoting cell
death in the spleen with an ability to induce Trail expression [159-162]. Moreover,
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Figure 5-8. Opposing roles for type I IFNs signaling and AIM2 inflammasome
responses during Francisella novicida infection in vivo.
cGAS-STING pathway induces production of type I IFNs in response to Francisella
novicida infection in vivo, leading to induction of TRAIL and TRAIL-dependent extrinsic
apoptotic cell death. On the other hand, AIM2 inflammasome is activated potentially via
bacteriolysis of Francisella by GBPs and IRGB10. The detrimental type I IFN signaling
overrides protective AIM2 inflammasome responses.
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Trail–/–- mice have decreased bacterial burdens in the liver and spleen and reduced splenic
cell death after L. monocytogenes infection [163]. Increased apoptosis during F. novicida
infection could lead to loss of hepatocytes, which have crucial roles in controlling
infection [164]. An expansion of IL-17-producing γδ T cells is attributed to the
phenotype of Ifnar1–/– mice in a previous study [155]. Since reduced activation of
apoptotic caspases in Ifnar2–/– and Ifnar2–/–Aim2–/– mice occurred as early as day 1 post
infection, preceding the elevation of IL-17 and IL-12 in the serum, it is intriguing to
hypothesize that certain immune cells such as γδ T cells may exhibit dampened cell death
in the absence of type I IFN signaling, leading to an increased production of circulating
IL-17 and IL-12. Type I IFN signaling is necessary for activating AIM2 inflammasome in
BMDMs infected with F. novicida via regulation of IRF1 and IRF1-mediated induction
of GBPs and IRGB10 [150]. However, in contrast to mice lacking type I IFN signaling,
mice lacking IRF1, GBPs or IRGB10 are susceptible to the infection due to impaired
AIM2 inflammasome responses [44, 47]. Since activation of AIM2 inflammasome is
IFNAR-independent in vivo, expression of IRF1, GBPs and IRGB10 might be intact in
mice lacking type I IFN signaling because of the redundant induction by other types of
IFNs. Consistent with this, priming Ifnar1–/– BMDMs with IFNγ bypasses the
requirement for type I IFN signaling in the activation of the AIM2 inflammasome
induced by F. novicida infection [45]. Overall, our work highlights the dominant role of
type I IFN signaling, which exacerbates F. novicida infection in vivo, as opposed to the
protective role of the AIM2 inflammasome.
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CHAPTER 6. GASDERMIN D MEDIATES PROTECTION AGAINST
FRANCISELLA NOVICIDA BY PROMOTING INFLAMMASOME
ACTIVATION
Introduction
Inflammasomes are innate immune multiprotein complexes formed by activation
of innate immune sensors including NOD-like receptors, AIM2 or pyrin in response to
pathogen-associated molecular patterns or danger-associated molecular patterns [63].
AIM2 is a cytoplasmic sensor for dsDNA. Upon activation, AIM2 assembles the
inflammasome complex with adaptor ASC to mediate caspase-1 activation and caspase1-dependent pyroptosis and release of pro-inflammatory cytokines IL-1 and IL-18 [3235].
GSDMD was recently discovered as an executioner of pyroptotic cell death
downstream of caspase-1 and caspase-11 [51-53]. GSDMD belongs to the gasdermin
family of proteins and is maintained in an auto-inhibitory form under steady state.
Inflammatory caspases including caspase-1 and -11 cleave at a link region between the
N- and C-terminal of GSDMD, releasing the N-terminal fragment from inhibited by the
C-terminal domain [51-53]. The N-terminal end of GSDMD binds to phosphoinositides
located in the inner leaflet of the plasma membrane and forms pores on the membrane
leading to cell lysis [54-58]. Recent studies have further shown that pores generated by
GSDMD can function as channels to allow secretion of IL-1 and IL-18 independently of
pyroptosis [59, 60].
AIM2 recognizes dsDNA originated from Gram-negative bacterium Francisella,
DNA viruses MCMV and vaccinia virus and host cells, thereby exhibiting crucial roles in
microbial infections and autoimmune diseases [41-43, 121, 165-167]. Mice lacking
AIM2, ASC or caspase-1 are highly susceptible to infection by F. novicida,
demonstrating a protective role for AIM2 inflammasome during the infection [41, 43-45,
47, 83, 168]. IL-1 and IL-18 have been further shown to mediate the beneficial effects
of AIM2 in response to Francisella tularensis Live Vaccine Strain [61, 62]. However, the
role of pyroptosis downstream of AIM2 inflammasome is unknown. In this study, we
showed that mice lacking the effector molecule of pyroptotic cell death, GSDMD, are
susceptible to F. novicida infection. We further found that although cleavage of GSDMD
is dependent on AIM2 inflammasome, GSDMD itself is required for optimal caspase-1
activation. Interestingly, GSDMD is also required for caspase-1 activation triggered by
other AIM2 inflammasome stimuli including poly(dA:dT) transfection and MCMV
infection.
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Results
GSDMD Is Required for Host Defense Against F. novicida Infection
Mice lacking AIM2 inflammasome components such as AIM2 (Aim2–/–) or
caspase-1 (Casp1–/–) were previously reported to be susceptible to F. novicida infection
[41, 43-45, 47, 83, 168]. Consistent with previous findings, we found that Aim2–/– and
Casp1–/– mice were susceptible to F. novicida infection (Figure 6-1A). Following
assembly of the inflammasome, activated caspase-1 cleaves pro-IL-1 and pro-IL-18 into
mature forms and mediates their release from the cell. We therefore tested the role of IL1 and IL-18 during F. novicida infection. Similar to Aim2–/– and Casp1–/– mice, mice
lacking both IL-1R and IL-18 (Il1r–/–Il18–/–) were also highly susceptible and succumbed
to death within 3 days of the infection (Figure 6-1A), highlighting a protective role for
IL-1 and IL-18 downstream of inflammasome activation during F. novicida infection.
GSDMD mediates pyroptosis downstream of AIM2 inflammasome in response to
DNA transfection [53]. To test the role of pyroptosis during F. novicida infection, we
infected WT mice and mice lacking GSDMD (Gsdmd–/–) with F. novicida and monitored
the survival. While 70% of WT survived on day 14 post infection, only 10% of Gsdmd–/–
mice survived during the course of infection (Fig. 1A). Furthermore, Gsdmd–/– mice had
significantly increased bacterial burden in the liver and spleen 3 days after F. novicida
infection (Figure 6-1B), further confirming a protective role for GSDMD. Pores formed
by GSDMD have been shown to mediate secretion of IL-1 and IL-18. Indeed, we
observed reduced level of circulating IL-18 in Gsdmd-/- mice compared to WT mice 1-day
post infection (Figure 6-1C).
GSDMD Is Necessary for Optimal Caspase-1 Activation by F. novicida
Inflammasome activation is critical for host defense against F. novicida infection
in vivo. To test whether inflammasome activation is affected in the absence of GSDMD,
we generated bone marrow-derived macrophages (BMDMs) from WT, Gsdmd–/– and
Aim2–/– mice. The population of CD11b+F4/80+ macrophage was comparable between
WT and Gsdmd–/– BMDMs (Figure 6-2A), suggesting that there is no difference in the
extent of macrophage differentiation. We then infected BMDMs from WT, Gsdmd–/– and
Aim2–/– mice with F. novicida and measured cleavage of pro-caspase-1 into its active
form (p20) following assembly of inflammasome. Interestingly, Gsdmd–/– BMDMs
showed decreased activation of caspase-1 compared to WT cells after F. novicida
infection (Figure 6-3A), highlighting the requirement of GSDMD for inflammasome
activation in response to F. novicida. Caspase-1 activation was reduced in Gsdmd–/–
BMDMs after infection with multiple MOIs of F. novicida (Figure 6-2B). In addition,
we observed impaired IL-1 and IL-18 release in F. novicida-infected Gsdmd–/– BMDMs,
potentially due to impaired caspase-1 activation along with defective pore formation
(Figure 6-3B), whereas secretion of TNF was similar between the cells (Figure 6-4).
GSDMD has been shown to mediate pyroptotic cell death upon AIM2 inflammasome
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Figure 6-1. GSDMD contributes to host defense against F. novicida infection.
(A) Survival of WT, Gsdmd−/−, Aim2−/−, Casp1−/− and Il1r−/−Il18−/− mice infected with F.
novicida. (B) Bacterial burden in the liver and spleen of WT and Gsdmd−/− mice 3 days
after infection with F. novicida. (C) Concentration of IL-18 in the sera of WT and
Gsdmd−/− 1 day after the infection. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 (logrank test [A] or two-tailed t test [B]). Data are pooled from two independent experiments
(A) or from one experiment (B–C); mean and SEM in B–C).
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Figure 6-2. GSDMD regulates caspase-1 activation and cell death after various
doses of F. novicida infection.
(A) Flow cytometric analysis of CD11b+F4/80+ BMDMs generated from WT and
Gsdmd–/– mice. (B) Immunoblot analysis of pro-caspase-1 (Pro-Casp-1) and the caspase1 subunit p20 (Casp-1 p20) in unprimed WT or mutant BMDMs left uninfected (medium
alone [Med]) or assessed 20 h after infection with varying MOIs (10, 50, 150 or 200) of
F. novicida. (C) Cell death analysis by Incucyte after infection as in (B). Data are
representative of two independent experiments (A–C; mean and SEM in C).
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Figure 6-3. GSDMD promotes casaspse-1 activation by F. novicida.
(A) Immunoblot analysis of pro-caspase-1 (Pro-Casp-1) and the caspase-1 subunit p20
(Casp-1 p20) in unprimed WT or mutant BMDMs left uninfected (medium alone [Med])
or assessed 20 h after infection with F. novicida (MOI, 100). (B) Release of IL-18 (left)
and IL-1β (right) in unprimed BMDMs after infection as in (A). (C and D) Cell death
analysis by Incucyte (C) or LDH release (D) after infection as in (A). (E) Representative
images of Sytox Green staining by Incucyte (Scale bar, 100 m) or light microscopy
(Scale bar, 25 m) of BMDMs after infection with F. novicida (MOI, 100). Arrowheads
indicate representative pyroptotic cells. **P<0.01, ***P<0.001, ****P<0.0001 (one-way
ANOVA with Dunnett’s multiple comparisons test [B and D]). Data are representative of
two (B), three (C, D and E) or six (A) independent experiments (mean and SEM in B, C
and D).
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Figure 6-4. TNF release is normal in the absence of GSDMD.
Release of TNF in unprimed BMDMs assessed 20 h after infection with F. novicida
(MOI, 100; left), 3 h transfection with poly(dA:dT) (middle), or 10 h infection with
MCMV (right). NS, not significant (one-way ANOVA with Dunnett’s multiple
comparisons test). Data are representative of two independent experiments (mean and
SEM).
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activation induced by cytoplasmic transfection of dsDNA [53]. To test the requirement of
GSDMD in pyroptosis triggered by F. novicida infection, we first monitored the extent of
cell death in WT, Gsdmd–/– and Aim2–/– BMDMs after F. novicida infection using Sytox
Green staining and found that Gsdmd–/– BMDMs exhibited lower number of Sytox-Green
positive cells than WT BMDMs over the course of the infection
(Figure 6-2C, Figure 6-3C, Figure 6-3E). Consistent with the Sytox green staining,
LDH release was also decreased in Gsdmd–/– BMDMs 20 hours post infection, which
further confirms that pyroptosis in BMDMs during F. novicida infection is dependent on
GSDMD (Figure 6-3D–E). Interestingly, GSDMD-independent cell death was also
observed in Gsdmd–/– BMDMs after F. novicida infection suggesting that other molecules
may exist to mediate F. novicida-induced pyroptosis (Figure 6-2C, Figure 6-3C–E).
GSDMD Is Necessary for Optimal Caspase-1 Activation by Other AIM2
Inflammasome Triggers
In addition to F. novicida infection, AIM2 inflammasome can also be activated by
transfection of poly(dA:dT) or MCMV infection. We found that caspase-1 activation
induced by transfection of dsDNA ligand, poly(dA:dT) was partially reduced in Gsdmd–/–
BMDMs compared with WT cells (Figure 6-5A). Gsdmd–/– BMDMs exhibited
compromised release of IL-18 but not TNF (Figure 6-5B, Figure 6-4). Consistent with
previous studies [53, 169], cell death was completely abolished in poly(dA:dT)transfected Gsdmd–/– BMDMs during the early phase of stimulation (Figure 6-5C–E).
Furthermore, MCMV-induced caspase-1 activation was dampened in Gsdmd–/– BMDMs
compared with WT BMDMs (Figure 6-5F). Release of IL-1 and IL-18 in MCMVinfected Gsdmd–/– BMDMs were impaired (Figure 6-5G), while TNF secretion was
comparable between WT and Gsdmd–/– BMDMs (Figure 6-4). Altogether, these data
demonstrate that GSDMD is necessary for optimal caspase-1 activation in response to
AIM2 inflammasome triggers including F. novicida and MCMV infection and, to a lesser
extent, poly(dA:dT) transfection and that GSDMD plays a critical role in mediating
pyroptosis after AIM2 inflammasome activation.
AIM2 Inflammasome Cleaves GSDMD during F. novicida Infection
Previous studies have shown that GSDMD is cleaved downstream of
inflammasome activation. To test if AIM2 inflammasome is able to mediate GSDMD
cleavage following F. novicida infection, we infected cells with F. novicida and observed
impaired cleavage of GSDMD in BMDMs lacking AIM2 (Aim2–/–) or ASC (Asc–/–)
(Figure 6-6A), suggesting that AIM2 inflammasome is required for GSDMD cleavage.
Type I IFN signaling is required for activating AIM2 inflammasome in macrophages
during F. novicida infection via induction of transcriptional factor IRF1, an interferonstimulated gene, which leads to IRF1-mediated expression of cell-autonomous immunity
proteins including GBP2, GBP5 and IRGB10, leading to bacteriolysis and release of
bacterial DNA [41-45, 47, 152, 155]. To investigate the involvement of GBPs in AIM2
mediated GSDMD cleavage, we utilized mice lacking multiple GBPs (including GBP2
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Figure 6-5. GSDMD is necessary for optimal casaspse-1 activation by other AIM2
inflammasome triggers.
(A) Immunoblot analysis of pro-caspase-1 (Pro-Casp-1) and the caspase-1 subunit p20
(Casp-1 p20) in unprimed WT or mutant BMDMs untreated (medium alone [Med]) or
assessed 3 h after transfection with poly(dA:dT). (B) Release of IL-18 in unprimed
BMDMs after treatment as in (A). (C and D) Cell death analysis by Incucyte (C) or LDH
release (D) after treatment as in (A). (E) Representative images of Sytox Green staining
by Incucyte (Scale bar, 100 m) or light microscopy (Scale bar, 25 m) of BMDMs after
transfection with poly(dA:dT). Arrowheads indicate representative pyroptotic cells. (F)
Immunoblot analysis of pro-caspase-1 (Pro-Casp-1) and the caspase-1 subunit p20 (Casp1 p20) in unprimed WT or mutant BMDMs left uninfected (medium alone [Med]) or
assessed 10 h after infection with 10 MOI of MCMV. (G) Release of IL-18 (left) and IL1β (right) in unprimed BMDMs after infection as in (F). *P<0.01, **P<0.01,
***P<0.001, ****P<0.0001 (one-way ANOVA with Dunnett’s multiple comparisons test
[B, D and G]). Data are representative of two (B, F and G), three (C, D, E) or six (A)
independent experiments (mean and SEM in B, C, D and G).
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Figure 6-6. GSDMD cleavage is dependent on AIM2 inflammasome.
(A and B) Immunoblot analysis of pro-GSDMD (GSDMD), cleaved N-terminal of
GSDMD (GSDMD-NT) and GAPDH in unprimed WT, Aim2–/– and Asc–/– BMDMs (A)
or WT and Gbpchr3-KO BMDMs (B) infected with F. novicida (MOI, 20). Data are
representative of two independent experiments (A and B).
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and 5) encoded on chromosome 3 (Gbpchr3-KO) and infected BMDMs from Gbpchr3-KO
mice with F. novicida. We found that Gbpchr3-KO BMDMs also exhibited reduced
cleavage of GSDMD (Figure 6-6B). Overall, these data demonstrate that although
caspase-1 activation induced by AIM2 inflammasome triggers is largely dependent on
GSDMD, GSDMD cleavage still requires AIM2 inflammasome.
Discussion
Pyroptosis is a lytic form of cell death that is induced by inflammasomes leading
to release of mature IL-1 and IL-18 and other cellular components including highmobility group box 1 (HMGB1) and IL-1. It has not been discovered until recently that
GSDMD induces pyroptosis by forming pores on plasma membrane after being activated
by caspase-1 or -11 [51-53]. In this study, we demonstrated a protective role for GSDMD
during F. novicida infection. While caspase-1 processing is intact in the absence of
GSDMD downstream of canonical NLRP3, NLRC4 or pyrin inflammasome [52, 53], we
observed that activation of caspase-1 is impaired in Gsdmd–/– BMDMs in response to
AIM2 inflammasome stimuli. Given that a residual amount of caspase-1 activation was
observed in Gsdmd–/– BMDMs infected with F. novicida, it is intriguing to hypothesize
that during the early phase of F. novicida infection, caspase-1 is activated in a GSDMD
independent manner. Activated caspase-1 may cleave GSDMD to allow the N-terminal to
target F. novicida in the cytosol leading to bacteriolysis and release of bacterial DNA,
which potentially amplifies activation of AIM2 inflammasome and further GSDMD
cleavage at later phase of F. novicida infection in a positive feedback manner. Indeed,
GSDMD has been shown to be associated with phosphoinositides and cardiolipin [54, 56,
57], the latter of which is a component of F. novicida membrane as well as mitochondria
[170]. Moreover, incubation of the N-terminal fragment of GSDMD with E. coli or
Staphylococcus aureus in vitro leads to reduced bacterial CFU [57]. Furthermore, higher
CFU of Listeria monocytogenes is observed in GSDMD-knocked down BMDMs [57],
revealing a bactericidal role for GSDMD during intracellular bacterial infection [56, 57].
Consistent with this hypothesis, we also observed a higher bacterial burden in
Gsdmd–/– mice after F. novicida infection. Polymers that facilitate transfection of
poly(dA:dT) or viral particles may be targeted by GSDMD similarly as F. novicida,
which explains a reduction in caspase-1 activation in the absence of GSDMD in response
to poly(dA:dT) transfection and MCMV infection. In addition to the possibility that
GSDMD targets bacterial membrane, GSDMD-mediated pore formation on plasma
membrane at early phase of F. novicida infection may act in a feed forward loop giving
an un-identified secondary signal for AIM2 inflammasome activation. It is also possible
that GSDMD binds to cardiolipin which is located at inner-membrane of mitochondria.
Pores may form by GSDMD on mitochondria inducing mitochondria damage and release
of mitochondria DNA or other mitochondria-associated molecules into cytosol, serving
as a potential source for AIM2 inflammasome activation. In addition, although levels of
cell death and release of IL-1β and IL-18 are greatly reduced in Gsdmd–/– BMDMs
stimulated with AIM2 inflammasome triggers compared with WT cells, the levels are
still higher than those in Aim2–/– BMDMs, suggesting that additional mechanisms may
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mediate pyroptosis and pyroptosis-dependent IL-1β and IL-18 release downstream of
AIM2 inflammasome activation. Consistent with our findings, GSDMD-independent cell
death and cytokine release are also reported previously [52, 169]. It is intriguing to
hypothesize that other members of GSDMD family such as GSDME can be activated by
AIM2 to induce pore formation on cell membrane leading to pyroptosis [171, 172].
Altogether, our study highlights a critical role for GSDMD in mediating host defense
against F. novicida infection and further underscores a requirement for GSDMD in
promoting optimal caspase-1 activation following AIM2 inflammasome triggers.
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CHAPTER 7. DISTINCT REGULATORY MECHANISMS CONTROL
PROINFLAMMATORY CYTOKINES IL-18 AND IL-1
Introduction
IL-18 and IL-1β, members of the IL-1 cytokine family, are important mediators of
inflammatory diseases and play critical roles in infection and cancer [65-67, 173]. Unlike
other cytokines, cellular IL-18 and IL-1β are synthesized as precursor proteins and need
to be cleaved to generate their biologically active forms. Inflammasome, a multimeric
protein complex, is a central regulator of this process by which bioactive IL-18 and IL-1β
are generated. The inflammasome comprises an innate immune sensor that includes the
NOD-like receptor, AIM2-like receptor, and pyrin; the adaptor protein ASC; and the
cysteine protease caspase 1 [36]. Inflammasome assembly induces the activation of
caspase-1, which mediates the proteolytic processing of pro-IL-18 and pro-IL-1β to
generate their bioactive forms and their release from the cell [36].
IL-18 is constitutively expressed in blood monocytes and intestinal epithelial cells
of healthy humans [68, 174]. It is also expressed in murine macrophages, dendritic cells,
endothelial cells, intestinal epithelial cells, and keratinocytes under steady state [175177]. However, IL-1β is not constitutively expressed under homeostasis. IL-1β
expression is induced in blood mononuclear cells, macrophages, and dendritic cells
during stimulation with TLR ligands and other cytokines (e.g., TNF) [65-67]. Unlike IL1β, a cellular pool for IL-18 already exists before an inflammatory stimulus, and is ready
to be activated and released by the inflammasome [64]. It must however be noted that
LPS-mediated priming of NLRP3 is required for inflammasome activation and
subsequent release of both IL-18 and IL-1 [178]. However, several studies suggest that
despite being constitutively expressed, IL-18 can also be induced under certain
circumstances. Treatment with LPS (TLR4 agonist) has been shown to upregulate the
mRNA levels of Il18 [68, 69]. Incubation of CpG oligonucleotides (TLR9 agonist) with
dendritic cells or infection of monocytes with the Sendai virus can also increase the
expression of Il18 [70, 71].
The mechanisms by which IL-18 and IL-1β levels are regulated by different
inflammatory signals remain unclear. In this study, we showed that expression of IL-18 is
induced and that the increased level is sustained during TLR4, TLR2, or TLR7 ligands
stimulation. In contrast, IL-1β expression declines soon after reaching its peak level. The
TLR3 and cGAS-STING pathways induced IL-18 but were modest at inducing IL-1β
expression. Importantly, type I IFN signaling was required to upregulate IL-18 in
response to all stimuli tested. Thus, in macrophages lacking components of type I IFN
signaling, IL-18 was not induced by any inflammatory stimuli. Together, our findings


Adapted with permission. Zhu, Q. and T.D. Kanneganti, Cutting Edge: Distinct
Regulatory Mechanisms Control Proinflammatory Cytokines IL-18 and IL-1β. J
Immunol, 2017. 198(11): p. 4210-4215. Copyright 2017. The American Association of
Immunologists, Inc.
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demonstrate that IL-18 and IL-1β expression are differentially regulated. Expression of
these inactive pro-inflammatory cytokines is an essential step for their maturation into
bioactive forms by caspase-1 inflammasomes. Overall, our data demonstrating
differential regulation of IL-18 and IL-1β will be fundamental to understanding several
inflammatory disease settings.
Results and Discussion
IL-18 and IL-1β Are Differentially Induced in Response to Inflammatory Stimuli
TLRs, one of the major types of pattern recognition receptors in the cell [179],
induce expression of pro-inflammatory cytokines and type I IFNs in response to
pathogen-associated molecular patterns and damage-associated molecular patterns [179].
We first confirmed that IL-18 was constitutively expressed in untreated WT BMDMs,
similar to previous reports [68, 175]. Interestingly, we observed that its expression was
upregulated by the TLR4 ligand LPS (Figure 7-1A). As expected, Il1b was not expressed
in untreated BMDMs but was induced shortly after LPS treatment (Figure 7-1A).
Interestingly, although gene and protein expression of IL-18 was sustained 24 hours after
stimulation, that of IL-1β was induced initially but reduced substantially at 24 hours
(Figure 7-1A). These results suggest that the expressions of IL-18 and IL-1β are
differentially regulated after LPS stimulation.
After binding to TLR4, LPS signals through both the MyD88 and TRIF pathways
[179]. To determine the specific roles of MyD88 and TRIF pathways in regulating IL-18
and IL-1β expression, we treated cells with ligands that signal through either the MyD88
or TRIF pathway. Interestingly, Pam3CSK4, which signals through the MyD88 pathway
downstream of TLR2 induced sustained expression of IL-18 over the treatment period in
WT BMDMs (Figure 7-1B). On the other hand, IL-1β was upregulated 4 hours after
treatment but diminished dramatically at later time points (Figure 7-1B). Gardiquimod
induces the MyD88 pathway downstream of TLR7. Induction kinetics of mRNA
expression and protein levels of IL-18 and IL-1β in WT BMDMs treated with
gardiquimod were similar to those treated with Pam3CSK4 (Figure 7-2). Poly(I:C) is
sensed by TLR3 to activate the TRIF pathway. Poly(I:C) treatment induced Il18
expression in WT BMDMs. It also induced Il1b expression, although at a much lower
fold induction than by LPS, Pam3CSK4, and gardiquimod (Figure 7-1C). These findings
suggest that the TRIF pathway moderately induces Il1b expression, and both the MyD88
and TRIF pathways induce Il18 expression. Taken together, our results show that IL-18
and IL-1β can be induced by various TLR ligands. Further, during chronic TLR
stimulation, IL-18 expression is sustained but IL-1β expression is downregulated. These
data suggest distinct regulatory pathways that control the expression of pro-IL-18 and
pro-IL-1β levels during chronic TLR stimulation.
One of the prominent mediators induced by the TRIF pathway are type I IFNs,
including IFNβ [179]. Poly(I:C) induced the expression of Il18 comparable to LPS

70

Figure 7-1. IL-18 and IL-1β are differentially expressed in response to
inflammatory stimuli.
(A–D) Real-time qPCR ana1ysis of genes encoding IL-18 and IL-1β and immunoblot
analysis of pro-IL-18, pro-IL-1β, and β-actin (loading control) in WT BMDMs at various
time points after LPS (A), Pam3CSK4 (B), poly(I:C) (C), or IFN-β (D) treatment. Data
are representative of three independent experiments

Figure 7-2. Kinetics of IL-18 and IL-1β expression stimulated by gardiquimod.
(A) Real-time qPCR analysis of the genes encoding IL-18 and IL-1β and immunoblot
analysis of pro-IL-18, pro-IL-1β and β-actin (loading control) in WT BMDMs at various
times after treated with gardiquimod. Data are representative of three independent
experiments.
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stimulation, which led us to hypothesize that the induction of Il18 requires type I IFNs.
To determine the role of type I IFNs in modulating the expressions of Il18 and Il1b, we
treated WT BMDMs with recombinant IFNβ and measured Il18 and Il1b expression. IL18 mRNA and protein levels were induced after IFNβ treatment, but IL-1β mRNA and
protein levels were only modestly induced at levels similar to those seen for Poly(I:C)
stimulation (Figure 7-1C−D). Overall, these data suggest that treatment of type I IFNs
upregulates IL-18 expression.
Induction of IL-18 but Not IL-1β Is Dependent on Type I IFN Signaling
To test whether type I IFN signaling was required for induction of Il18 expression
by inflammatory stimuli, we treated WT BMDMs and cells lacking the subunit of type I
IFN receptor IFNAR1 (Ifnar1−/−) with LPS and monitored the expression of Il18 and Il1b
over the treatment period. LPS treatment led to upregulation of IL-18 in WT BMDMs as
early as 4 hours after treatment. IL-18 expression further increased and was sustained
during chronic LPS treatment (Figure 7-3A). Surprisingly, this induction of IL-18 by
LPS was impaired in Ifnar1−/− cells (Figure 7-3A), indicating that type I IFN signaling is
crucial to induce IL-18 during LPS treatment. In WT BMDMs, IL-1β expression
increased 4 hours and 8 hours after treatment but diminished at later time points
(Figure 7-3A). Unlike Il18, induction of IL-1β remained largely intact in Ifnar1−/− cells
(Figure 7-3A). Moreover, expression of Il1b mRNA and protein was higher in Ifnar1−/−
BMDMs than in WT BMDMs 16 hours and 24 hours after stimulation (Figure 7-3A),
suggesting that type I IFN signaling may negatively regulate Il1b expression during
chronic LPS stimulation.
To further test whether the induction of IL-18 by stimuli that trigger only the
MyD88 or TRIF pathway also depends on type I IFN signaling, we treated WT and
Ifnar1−/− BMDMs with Pam3CSK4, gardiquimod, or Poly(I:C). Induction of IL-18 was
abolished in Ifnar1−/− BMDMs compared with WT BMDM when MyD88 signaling was
triggered by Pam3CSK4 or gardiquimod treatment (Figure 7-3B−C). However, IL-1β
expression remained unchanged in Ifnar1−/− BMDMs after either stimulation (Fig. 2B and
2C). Further, during treatment with Poly(I:C), which signals via the TRIF pathway, IL-18
induction was impaired in Ifnar1−/− BMDMs compared with WT BMDMs (Figure 7-3D).
Recognition of cytosolic DNA by the cGAS-STING pathway results in the production of
type I IFNs [10]. We hypothesized that stimuli that induce the production of type I IFNs
will promote IL-18 expression that is dependent on type I IFN signaling. Therefore, we
activated the cGAS-STING pathway by transfecting double-stranded DNA, poly(dA:dT),
or the STING ligand cGAMP in BMDMs. Expression of Il18 was increased by activation
of the cGAS-STING pathway (Figure 7-3E−F), but that of Il1b was not robustly induced
(Figure 7-3E−F). As expected, the induction of Il18 was lower in Ifnar1−/− BMDMs in
response to poly(dA:dT) or cGAMP than in WT BMDMs (Figure 7-3E−F). Collectively,
these results suggest that type I IFN signaling is critical for induction of IL-18, but not
IL-1β after inflammatory stimulations.
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Figure 7-3. Type I IFN signaling is essential for induction of IL-18 but not IL-1β.
(A) Immunoblot analysis of pro-IL-18, pro-IL-1β, and β-actin (loading control) and realtime qPCR analysis of genes encoding IL-18 and IL-1β in WT or Ifnar1−/− BMDMs at
various time points after LPS treatment. (B–D) Immunoblot analysis of pro-IL-18, proIL-1β, and β-actin (loading control) in WT or Ifnar1−/− BMDMs at various time points
after Pam3CSK4 (B), gardiquimod (C), or poly(I:C) (D) treatment. (E and F)
Immunoblot analysis of pro-IL-18, pro-IL-1β, and β-actin (loading control) in untreated
WT or Ifnar1−/− BMDMs (medium alone [Med]) or BMDMs at 8 h after transfected with
poly(dA:dT) (E) or 2’3’-cGAMP (cGAMP) (F). Data are representative of three
independent experiments.
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Components of Type I IFN Signaling Are Essential to Induce IL-18
The type I IFN receptor is a heterodimeric complex formed by IFNAR1 and
IFNAR2 [180]. Binding of type I IFN to IFNAR1 and IFNAR2 induces the formation of
ISGF3 by STAT members STAT1, STAT2, and IRF9, which function as transcriptional
factors to induce the expression various interferon-stimulated genes (ISGs) [180]. To test
whether other components of type I IFN signaling are also required to induce IL-18, we
first measured IL-18 and IL-1β levels in WT BMDMs and cells lacking IFNAR2, IRF9,
or STAT1 (Ifnar2−/−, Irf9−/− and Stat1−/−, respectively) after LPS treatment. Similar to
Ifnar1-/- BMDMs, induction of IL-18 was also impaired in Ifnar2−/−, Irf9−/−, and Stat1−/−
BMDMs (Figure 7-4A). However, expression of Il1b mRNA and protein was not
compromised but showed a slight increase at 16 hours and 24 hours after stimulation in
Ifnar2−/−, Irf9−/−, and Stat1−/− BMDMs (Figure 7-4A). Moreover, pro-IL-18 was not
upregulated in Ifnar2−/−, Irf9−/−, and Stat1−/− BMDMs treated with Pam3CSK4 or
Poly(I:C) compared with WT BMDMs (Figure 7-4B−C). ISGF3 directly binds to
promoters of ISGs to induce their expression, some of which include IRFs that function
as transcriptional factors to drive the expression of additional genes [181]. To test
whether IL-18 was induced via ISGF3 or other IRFs downstream of the type I IFN
receptor, we stimulated Ifnar1−/−, Ifnar2−/−, Irf9−/−, and Stat1−/− BMDMs with
recombinant IFNβ and observed that IFNβ–induced expression of Il18 was compromised
in Ifnar1−/−, Ifnar2−/−, Irf9−/−, and Stat1−/− BMDMs compared with WT cells
(Figure 7-5A). On the other hand, the induction of Il18 by IFNβ was not affected in
BMDMs lacking other IRFs, including IRF1, IRF3, IRF4, IRF5, IRF7, or IRF8 (Irf1−/−,
Irf3−/−, Irf4fl/fl-Lysm-Cre, Irf5−/−, Irf7−/− and Irf8−/−, respectively; Figure 7-5B−C),
suggesting that induction of Il18 is dependent on ISGF3 but not other IRFs.
We have established that although both IL-18 and IL-1β belong to the IL-1 family
and are activated by the inflammasome, IL-18 and IL-1β are differentially regulated
(Figure 7-5D). Indeed, previous report has shown that secretion of IL-1β but not IL-18
from murine dendritic cells in response to Listeria monocytogenes p60 protein requires
ROS production and caspase 11 [182]. Distinctive expression patterns of IL-18 and IL-1β
are observed in the intestine. IL-18 is expressed at high level in colon and confers
protection against inflammation by promoting epithelial cell proliferation and tissue
repair [183]. IL-1β, on the other hand is expressed at lower levels basally, but enhanced
during acute inflammation [183]. Given that type I IFNs are protective against DSSinduced colitis [184], it is possible that the type I IFNs contribute to protection by
upregulating the expression of Il18 in the colon. Activation of the cGAS-STING pathway
leads to the production of type I IFN [10]. Colon tissues from mice lacking STING also
have decreased Il18 mRNA and protein expression after DSS treatment [143, 185].
Therefore, type I IFN signaling can be explored as a therapeutic target in IL-18–
associated diseases. We further demonstrated that Il1b gene and protein expression was
reduced during chronic TLR stimulation in WT BMDMs, indicating that the transcription
of Il1b or stability of Il1b mRNA may be compromised. Reduced translational activity or
protein stability can also contribute to decreased levels of pro-IL-1β. Indeed, there is
translational inhibition of Il1b expression in LPS-stimulated macrophages [186].
Moreover, pro-IL-1β is ubiquinated by E2 conjugase UBE2L3 and subsequently
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Figure 7-4. Components of type I IFN signaling are required for induction of IL18.
(A) Immunoblot analysis of pro-IL-18, pro-IL-1β, and β-actin (loading control) and realtime qPCR analysis of genes encoding IL-18 and IL-1β in WT, Ifnar2−/−, Irf9−/−, or
Stat1−/− BMDMs at various time points after LPS treatment. (B and C) Immunoblot
analysis of pro-IL-18, pro-IL-1β, and β-actin (loading control) in WT, Ifnar2−/−, Irf9−/−, or
Stat1−/− BMDMs at various time points after Pam3CSK4 (B) or poly(I:C) treatment (C).
Data are representative of three independent experiments.
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Figure 7-5. Type I IFNs induce IL-18 expression via ISGF3 and a model of
differential regulation of pro-inflammatory cytokines IL-18 and IL-1β.
(A) Immunoblot analysis of pro-IL-18 and β-actin (loading control) in WT, Ifnar2−/−,
Irf9−/− or Stat1−/− BMDMs at various times after treated with IFNβ. (B) Real-time qPCR
analysis of the gene encoding IL-18 in WT, Irf1−/−, Irf3−/−, Irf5−/−, Irf7−/− or Irf8−/−
BMDMs at various times after treated with IFNβ. (C) Real-time qPCR analysis of the
gene encoding IL-18 in WT or Irf4fl/fl-Lysm-Cre BMDMs at various times after treated
with IFNβ. (D) Expression of IL-18 is induced and sustained by stimulations of TLR2,
TLR4, or TLR7 ligand, while IL-1β expression declines soon after reaching its peak
level. The TLR3 and cGAS-STING pathways also upregulate IL-18 expression but are
modest at inducing IL-1β expression. Importantly, type I IFN signaling downstream of
TLRs and cGAS-STING pathway is crucial in mediating IL-18 induction. Data are
representative of three independent experiments.
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degraded during chronic LPS stimulation [187]. This observation is in line with several
studies showing that when macrophages are treated with TLR ligands, pro-IL-1β is
sequestered in autophagosomes for degradation [188, 189]. Of note, we found that
although increases in mRNA levels were similar between Il18 and Il1b in response to
Poly(I:C) in WT BMDMs, upregulation of IL-1β protein levels was much less robust
compared with that of IL-18 levels (Fig. 1C). This could be resulted from decreased
translational activity of Il1b mRNA or lower stability of pro-IL-1β due to proteasome or
autophagy-mediated degradation, revealing another layer of differential regulation
between IL-18 and IL-1β. In addition, the modest expression of IL-1β in response to
Poly(I:C) is supported by a previous study showing that pro-IL-1β is much less induced
by Poly(I:C) than by LPS or gardiquimod [190]. Our study also found that
downregulation of both Il1b mRNA and protein expression was ameliorated in cells
lacking type I IFN signaling at later time points of LPS stimulation. An intriguing theory
is that type I IFN signaling may be involved in the negative control of Il1b expression.
Indeed, macrophages lacking tyrosine kinase 2, which is downstream of the type I IFN
receptor, have increased translation of Il1b and hence high levels of pro-IL-1β in
response to LPS [191]. Previous study has also demonstrated that type I IFN signaling
suppresses IL-1β expression via IL-10-STAT3 signaling axis and inhibits proteolytic
processing of IL-1β by NLRP3 inflammasome [192]. Interestingly, downregulation of
IL-1β expression was not affected in BMDMs lacking type I IFN signaling compared
with WT cells at later time points of Pam3CSK4 or gardiquimod stimulation (Fig. 2B,
2C, 3B and 3C). The MyD88 pathway might induce lower production of type I IFNs and
consequently the negative control on IL-1β is less robust as compared to the TRIF
pathway that is activated by LPS.
IL-1 family cytokines have pleiotropic functions and are involved in several
inflammatory and autoinflammatory disease settings. Interestingly, IL-1, IL-1β and IL18 have specific functions in regulating disease outcomes [36]. Autoinflammatory
models associated with overt pyrin inflammasome activation are differentially mediated
through IL-18 [193] or IL-1β [194] production. While levels of circulating IL-1β and IL18 in the serum are upregulated in patients bearing activating NLRC4 or NLRP3
mutation, IL-18 is induced to a greater extent in patients harboring mutation in NLRC4
[195]. IL-18 is also chronically elevated in several of the autoinflammatory diseases and
inflammasomepathies [196]. However, the cause and effect of this chronically sustained
elevated level of IL-18 is not studied well. Our current studies demonstrate that targeting
type I IFN signaling pathway could be a way to regulate the pathologic level of IL-18 in
the affected patients. In summary, our study demonstrated that during chronic
stimulation, IL-18 expression is induced and sustained. In contrast, during chronic
stimulations IL-1β is robustly induced but not sustained. Finally, we show that type I IFN
signaling is necessary for the induction of IL-18, but not IL-1β, which points to a critical
and differential role for type I IFN in regulating IL-18 signaling.
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CHAPTER 8.

DISCUSSIONS

Cytosolic nucleic acid sensors are pattern recognition receptors that mediate a
range of physiological and pathological conditions. STING functions as an adaptor for
cytosolic DNA sensing pathway induced by cGAS [10]. Our results demonstrated that
STING is critical for protection against colon cancer by controlling overt colon
inflammation, possibly through mediating activation of caspase-1 and casepase-1dependent IL-18 release. Shortly after our work was published [143], studies from other
groups showed that expression of cGAS or STING is lost in colon carcinoma cell lines or
gastric cancer [197, 198]. Moreover, tumor DNA has been identified to be recognized by
cGAS-STING pathway in antigen-presenting cells leading to their activation, a process
that requires production of type I IFNs induced by cGAS and STING [199, 200].
Activated antigen-presenting cells then induce potent anti-tumor CD8+ T cell responses.
STING agonists have been further shown to provide anti-tumor responses in mouse
models of melanoma, sarcoma, colon carcinoma, glioma, breast carcinoma, upper
aerodigestive squamous cell carcinoma and pancreatic carcinoma [199-205]. The antitumorigenic properties of STING ligands in a variety of tumor types indicate a need to
evaluate therapeutic values of STING agonists in the clinic. Indeed, small molecules that
activate STING pathway are currently undergoing Phase I clinical trials to treat patients
with solid tumors or lymphomas (NCT02675439 and NCT03172936). In addition, given
that cGAMP has been recently shown to activate inflammasome in a STING-dependent
manner in both mouse and human myeloid cells [112, 113], it is especially important to
monitor inflammasome responses in those cancer patients administrated with STING
ligands.
We have also demonstrated that the DNA sensor AIM2 plays a critical role in
preventing against colon cancer induced by AOM and DSS treatment. Although AIM2
forms the inflammasome complex with ASC and caspase-1 upon its recognition of
cytosolic dsDNA, we showed that inflammasome responses were intact in the absence of
AIM2 during the tumor development, as indicated by similar activation level of caspase-1
and release of IL-18 and IL-1β in the colon and sera as WT mice. The finding showing an
inflammasome-independent role for AIM2 in colon cancer is confirmed by a second
study [206]. To further demonstrate this, it would be helpful to cross Aim2−/− mice with
mice lacking other components such as Casp1−/− mice, and compared tumor outcome
between Aim2−/− mice, Casp1−/− mice and Aim2−/−Casp1−/− mice. The inflammasomeindependent role for AIM2 in regulating tumor development would suggest an additive
effect of tumor suppression by AIM2 and caspase-1 and that an enhanced tumor burden
would be observed in Aim2−/−Casp1−/− mice compared with Aim2−/− mice or Casp1−/−
mice following AOM and DSS treatment. The second study further identified that AIM2
interacts with DNA-dependent protein kinase (DNA-PK), a protein of PI3K-related
family to restrict activation of AKT pathway downstream of the kinase in response to the
growth factor, insulin-like growth factor-1 (IGF-1) [206]. It would be interesting to
identify and generate AIM2 mutants with an impaired ability to form inflammasome
induced by cytosolic dsDNA but being able to bind to DNA-PK to regulate AKT
pathway. We have also discovered that AIM2 negatively controls intestinal stem cell
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activity by crossing Aim2−/− with Prom1CreERT2-LacZ (C-L)/+; Ctnnb1lox(ex3)/+; RosaZsGreen
mouse strain and observed increased generative capacity of stem cells in
Aim2−/−;Prom1CreERT2-LacZ (C-L)/+; Ctnnb1lox(ex3)/+; RosaZsGreen compared with
Aim2+/+;Prom1CreERT2-LacZ (C-L)/+; Ctnnb1lox(ex3)/+; RosaZsGreen. To investigate the role of
AIM2 in stem cell function more directly, it would be ideal to have Aim2fl/fl mice crossed
with Prom1CreERT2-LacZ (C-L)/+; Ctnnb1lox(ex3)/+; RosaZsGreen mice to delete AIM2 in
Prom1+ stem cell compartment and its progeny specifically.
AIM2 recognizes bacterial, viral or self-derived DNA in the cytosol and forms an
inflammasome complex leading to maturation and release of IL-1β and IL-18 and
pyroptotic cell death [1]. AIM2 inflammasome is critical for induction of immune
responses when host encounters a variety of infectious agents including F. novicida.
While type I IFN signaling is required for activating AIM2 inflammasome after F.
novicida infection [1]. We found that AIM2 inflammasome activation is intact in mice
lacking type I IFN signaling in response to F. novicida, suggesting that type I IFN
signaling is not required for AIM2 inflammasome activation in vivo. We showed that
components of type I IFN signaling pathway are detrimental to the host survival during
F. novicida infection, which is consistent with a previous study using mice lacking one
subunit of type I IFN receptor IFNAR1 [155]. Furthermore, the deleterious type I IFN
signaling dominates against protective AIM2 inflammasome responses by activating
TRAIL-mediated apoptotic cell death pathway. Types of cells that are responsible for
producing type I IFNs and TRAIL during the infection are still remained to be
discovered. Moreover, it is intriguing to identify which cell types undergo apoptosis in a
type I IFN signaling-dependent manner leading to the susceptibility to F. novicida
infection. We observed induction of apoptotic cell death in F. novicida-infected liver
tissues, where the majority of cells are hepatocytes. It is likely that hepatocytes are
targeted by type I IFNs to cell death in the liver during the infection. Apoptosis may also
occur in immune cells including inflammatory monocytes and tissue-resident
macrophages such as Kupffer cells, which have important roles in antimicrobial
activities.
We further explored the role of GSDMD downstream of AIM2 inflammasome
during F. novicida infection. Consistent with the susceptibility of mice lacking AIM2,
ASC or caspase-1 [41, 43-45, 47, 83, 168], mice lacking GSDMD were also more
sensitive to the infection. Interestingly, we further discovered that GSDMD is required
for optimal caspase-1 activation in response to F. novicida, despite the fact that AIM2
inflammasome still mediates cleavage of GSDMD to release its functional N-terminal
fragment. GSDMD has been generally considered as the executioner of pyroptosis, our
findings advance current understanding of the function of GSDMD and suggest a role for
GSDMD in regulating activation of AIM2 inflammasome. In addition to AIM2
inflammasome, GSDMD is cleaved by caspase-11 leading to activation of non-canonical
NLRP3 inflammasome [52]. It is intriguing to hypothesize that GSDMD activates AIM2
inflammasome or non-canonical NLRP3 inflammasome by a shared mechanism via pore
formation on the membrane of an unknown source.
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Our findings on distinctive mechanisms regulating the expression of
inflammasome-associated cytokines IL-1β and IL-18 may provide explanations on
several autoimmune diseases or infections where IL-1β and IL-18 have differential roles
[65-67, 81, 173, 207, 208]. Given that induction of IL-18 is dependent on type I IFN
signaling in BMDMs, effects of IL-18 should be taken into accounts in clinical therapies
that modulate type I IFN signaling [209]. Consistent with our work, IL-18 expression is
observed to be downregulated in Ifnar1−/− BMDMs in response to influenza virus [210].
Type I IFN signaling has also been shown to mediate IL-18 production by inflammatory
monocytes during herpes simplex virus (HSV)-2 infection leading to the activation of
natural killer (NK) cells [211], further highlighting the significance of our findings under
pathological conditions.
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